<SEC-DOCUMENT>0000719135-23-000066.txt : 20231128
<SEC-HEADER>0000719135-23-000066.hdr.sgml : 20231128
<ACCEPTANCE-DATETIME>20231128165701
ACCESSION NUMBER:		0000719135-23-000066
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20231121
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231128
DATE AS OF CHANGE:		20231128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apyx Medical Corp
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31885
		FILM NUMBER:		231447281

	BUSINESS ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760
		BUSINESS PHONE:		7273842323

	MAIL ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL Corp
		DATE OF NAME CHANGE:	20150319

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL CORP
		DATE OF NAME CHANGE:	19990216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AN CON GENETICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>apyx-20231121.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:8e91d6bb-3e52-44e0-a79f-ce7b8f902cfd,g:5d28ccab-7708-4f10-910c-060a6fbe0eb5,d:35ec620316044296a83e3dbb0694e806--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>apyx-20231121</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000719135</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="apyx-20231121.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-21</xbrli:startDate><xbrli:endDate>2023-11-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i35ec620316044296a83e3dbb0694e806_1"></div><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 21, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div style="text-align:center"><img src="apyx-20231121_g1.jpg" alt="apyx8klogo.jpg" style="height:139px;margin-bottom:5pt;vertical-align:text-bottom;width:225px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">APYX MEDICAL CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-31885</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">11-2644611</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">5115 Ulmerton Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Clearwater</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33760</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(Address of principal executive offices, zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">727</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">384-2323</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Issuer's telephone number)</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:38.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class A common stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">APYX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i35ec620316044296a83e3dbb0694e806_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Appointment of Matthew Hill as Chief Financial Officer </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 28, 2023, Apyx Medical Corporation (</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the &#8220;Company&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">announced that it had appointed Matthew Hill as its Chief Financial Officer, effective December 4, 2023 (the &#8220;Effective Date&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Immediately prior to joining the Company, Mr. Hill, age 55, served as the Chief Financial Officer of PDS Biotechnology Corporation (Nasdaq: PDSB) (&#8220;PDS Biotech&#8221;), a clinical-stage immunotherapy company, where he led all aspects of the company&#8217;s budgeting, forecasting, financial management and reporting. Prior to joining PDS Biotech, he served as Chief Financial Officer of Strata Skin Sciences (Nasdaq: SSKN), a medical technology company developing, commercializing and marketing products for the treatment of dermatologic conditions, from 2018 to 2021. Prior to joining Strata Skin Sciences, Mr. Hill served as Chief Financial Officer at several companies, including Velcera, Inc., which developed pet medication for the companion animal health industry, and EP MedSystems, which developed and marketed cardiac electrophysiology products. He was also a Senior Manager at the international accounting and consulting firm, Grant Thornton LLP. Mr. Hill holds a Bachelor of Science in Accounting from Lehigh University.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">With the exception of Mr. Hill&#8217;s Employment Agreement described below, there are no arrangements or understandings between Mr. Hill and any other person pursuant to which Mr. Hill was selected as Chief Financial Officer. Mr. Hill does not have any familial relationships with any director or executive officer of the Company. The Company has not engaged in any transaction with Mr. Hill that requires disclosure under Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Employment Agreement with Matthew Hill </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 21, 2023, in connection with his appointment as Chief Financial Officer, the Company entered into an Employment Agreement with Mr. Hill, effective December 4, 2023 (the &#8220;Employment Agreement&#8221;). On the Effective Date, Mr. Hill will also serve as the Company&#8217;s Principal Financial Officer and Principal Accounting Officer.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the terms of the Employment Agreement, Mr. Hill will receive an initial annual base salary of $425,000 (the &#8220;Base Salary&#8221;). Mr. Hill will also be entitled to receive a sign on bonus of $50,000 within 30 days of the Effective Date, subject to the recoupment of any unearned portion if Mr. Hill is terminated for Cause (as defined therein) or Mr. Hill terminates the Employment Agreement without Good Reason (as defined therein) prior to the one-year anniversary of the Effective Date. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, Mr. Hill shall have the opportunity to earn an annual bonus under a bonus plan to be determined and established by the Company. The target bonus shall be equal to not less than 50% of his Base Salary, subject to the achievement of bonus objectives. Pursuant to an option award agreement between Mr. Hill and the Company that will be delivered to Mr. Hill in or about January 2024, Mr. Hill will also be entitled to receive a non-qualified stock option to purchase 150,000 shares of the Company&#8217;s common stock at an exercise price equal to the closing price of the Company&#8217;s common stock on its principal exchange on the date of such grant, subject to the applicable vesting requirements. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Mr. Hill&#8217;s employment with the Company is terminated for any of the reasons set forth in the Employment Agreement, Mr. Hill (or his estate or beneficiaries in the case of his death) shall receive certain earned but unpaid amounts and other benefits, provided (i) a Release (as defined in the Employment Agreement) is executed and the applicable revocation period with respect to the Release expires without any revocation of any portion of the Release, and (ii) none of the Restrictive Covenants (as defined in the Employment Agreement) are breached.   </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The foregoing is only a summary of the material terms of the Employment Agreement and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is attached hereto as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01   Regulation FD Disclosure.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 28, 2023, the Company issued a press release (the &#8220;Press Release&#8221;) announcing the appointment of Mr. Hill as its Chief Financial Officer. A copy of the Press Release is attached hereto as Exhibit 99.1.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Item 7.01 and in Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of such information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01              Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="apyxemployment_agreementwi.htm">Employment Agreement, effective as of December 4, 2023, by and between the Company and Matthew Hill.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cfoappointmentpressrelease.htm">Press release dated November 28, 2023.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i35ec620316044296a83e3dbb0694e806_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.275%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 28, 2023</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Apyx Medical Corporation</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Charles D. Goodwin, II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin, II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheif Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>apyxemployment_agreementwi.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iee4182c04fea407db196cbcf751185ca_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EMPLOYMENT AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS EMPLOYMENT AGREEMENT, effective as of December 4, 2023 (the &#8220;Effective Date&#8221;), is hereby entered into by and between Apyx Medical Corporation, a corporation organized and existing under the laws of the State of Delaware (the &#8220;Company&#8221;) and Matthew Hill</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Executive&#8221;).</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WITNESSETH&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company agrees to employ the Executive and the Executive agrees to be employed by the Company on the terms and conditions set forth herein. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, for and in consideration of the mutual covenants contained herein, the parties hereto agree as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">EMPLOYMENT OF EXECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The Company hereby employs the Executive and the Executive hereby accepts employment with the Company, in each case pursuant to the terms and conditions of this Agreement.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">DUTIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The Executive shall be the Chief Financial Officer of the Company and shall have the authority, functions, duties, powers and responsibilities normally associated with such position, and such other title, authority, functions, duties, powers and responsibilities as may be assigned to the Executive from time to time by the Chief Executive Officer of the Company (&#8220;CEO&#8221;) and the Board of Directors of the Company (the &#8220;Board&#8221;) consistent with the Executive&#8217;s position with the Company.  Executive shall report to the CEO. The Executive agrees to devote substantially all of his business time and efforts to the performance of his duties, except for customary vacations and reasonable absences due to illness or other incapacity as set forth herein, and to perform all of his duties to the best of his professional ability and comply with such reasonable policies, standards, and regulations of the Company as are from time to time established by the Board.  Executive shall have no outside business activities that are competitive with or present a conflict of interest with the Company, or that would conflict or interfere with the performance of his duties hereunder.  Notwithstanding the foregoing, nothing contained herein shall be construed so as to prohibit or prevent the Executive from engaging in charitable causes, sitting on the boards of directors of not-for-profit entities, or managing his and his family&#8217;s personal finances, so long as such activities do not conflict or interfere with the performance of his duties hereunder. By entering into this Agreement, the Executive represents that he is not a party to any restrictive covenants, or other agreement or understanding that would conflict or interfere with the performance of any of his duties hereunder.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">TERM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The term of employment under this Agreement shall commence on the Effective Date and shall continue until terminated in accordance with Section 11 hereof (the &#8220;Term&#8221;).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">PLACE OF EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; Executive&#8217;s principal work location shall be in Lumberton, New Jersey.  Executive shall travel to such other locations as reasonably necessary to carry out his duties hereunder on an as-needed basis. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">COMPENSATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; For all services rendered to the Company, the Executive agrees to accept as total compensation a sum computed as set forth in this Section 5. All payments of compensation (whether under this Section 5 or under any other section of this Agreement) shall be subject to all applicable withholdings and deductions in accordance with applicable law and Company policies and procedures.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819466&#47;v3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall pay the Executive an annual base salary at the rate of Four Hundred Twenty Five Thousand Dollars ($425,000.00) per year (&#8220;Base Salary&#8221;), in accordance with the customary payroll practices of the Company applicable to senior executives. During the Term, the Company&#8217;s Compensation Committee of the Board shall review the Base Salary and may provide for such increases (but not decreases) in Base Salary as it may, in its sole and exclusive discretion, deem appropriate. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Annual Incentive Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  During the Term, the Executive shall have the opportunity to earn an annual bonus under a bonus plan to be determined and established annually by the Company (the &#8220;Bonus Plan&#8221;).  The Bonus Plan shall be subject to prior Board approval.  The criteria used to determine the amount of the Executive&#8217;s annual bonus (&#8220;Performance Bonus&#8221;) under the Bonus Plan will be established by the Company in its sole discretion, and shall have a target bonus in an amount equal to not less than 50% of the Executive&#8217;s Base Salary. The Performance Bonus will be paid no later than April 30 of the following calendar year.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Sign-On Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As a further inducement to execute this Agreement and commence and continue employment with the Company, the Company shall pay to the Executive, in a single lump sum within 30 days following the Effective Date, the gross amount of Fifty Thousand Dollars ($50,000) (&#8220;Sign-On Bonus&#8221;).  The amount equal to 1&#47;12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Sign-On Bonus shall be earned by Executive for each full month of employment that he works for the Company beginning as of the Effective Date.  In the event that the Executive terminates his employment without Good Reason, as defined in Section 11(d), or is terminated for Cause, as defined in Section 11(b), prior to the one-year anniversary of the Effective Date, the Executive agrees that he shall reimburse the Company for the unearned portion of the Sign-On Bonus within 30 days of his termination of employment.   </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.67pt">General.  Executive shall be eligible to participate in the equity-based incentive plans of the Company and may receive awards thereunder, as determined by the Compensation Committee from time to time and subject to the terms and conditions of such plans and any award agreement between the Company and Executive evidencing such awards.</font></div><div style="text-align:justify;text-indent:108pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.67pt">Sign-On Award.  Pursuant to an option award agreement between the Company and the Executive that shall be delivered to the Executive in or about January 2024 (the &#8220;Award Agreement&#8221;) the Company shall grant to the Executive a non-qualified stock option (an &#8220;Option&#8221;) to purchase 150,000 shares of Apyx common stock at an exercise price equal to the closing price of the shares of the Company&#8217;s common stock on its principle exchange on the date of the grant.  The Options will vest as follows&#58; 50% on the first anniversary of Executive&#8217;s commencement of employment and the remaining 50% on the second anniversary of Executive&#8217;s commencement of employment.  Executive must be employed by the Company on the vesting dates referenced in the prior sentence in order for the Options to vest. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.67pt">All unvested Options and other equity-based incentive plans will vest immediately upon a Change of Control (as defined in Section 11(f) below).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">VACATION&#47;SICK TIME</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; Executive shall be entitled to paid time off during Executive's employment pursuant to the Company&#8217;s policies applicable to senior executives, as may be amended from time to time. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">REIMBURSEMENT OF BUSINESS EXPENSES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The Company agrees to pay, either directly or indirectly by payment to the Executive, for all of the Executive's reasonable entertainment, travel and other miscellaneous business expenses incurred by him in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">performance of his services under this Agreement, in accordance with the Company&#8217;s policies regarding such reimbursements. As a prerequisite to any payment or reimbursement by the Company for business expenses, the Executive shall submit receipts of all such expenses to the Company&#59; and the Company's obligation to effect payment or reimbursement of such expenses shall be only to the extent of such receipts. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">ADDITIONAL BENEFITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The Executive and his dependents shall be eligible to participate in the Company&#8217;s medical and dental insurance plans applicable to senior executives at the Company in accordance with the terms and conditions of such plans.  </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt;text-decoration:underline">COMPANY PROPERTY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The Executive understands and agrees that Company files, customer files, legal files, legal research files, form files, forms, examples, samples, and all briefs and memoranda, intellectual property and other work product or property, and all copies thereof (collectively, &#8220;Company Property&#8221;) are the sole and exclusive property of the Company&#59; and the same shall remain in the possession of the Company and shall constitute the property of the Company irrespective of who prepared the same.  The Executive shall not remove, photocopy, photograph, or in any other manner duplicate or otherwise remove or use any Company Property other than in the performance of his duties hereunder.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">DISPOSITION OF PROPERTY UPON TERMINATION OF EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; In the event that Executive&#8217;s employment with the Company is terminated for any reason, the Executive agrees and understands that all Company Property in his possession or control shall be, at the Company&#8217;s option, promptly destroyed or returned to the Company, and the Executive shall have no right, title or interest in the same. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">TERMINATION OF EMPLOYMENT AND CHANGE OF CONTROL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  Upon Executive&#8217;s termination of employment for any reason, he shall automatically be deemed to have stepped down from all positions and offices held with the Company.  The employment of the Executive may be terminated as follows&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination upon Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement and the Executive&#8217;s employment hereunder shall automatically terminate on the date on which the Executive dies or becomes permanently incapacitated. The Executive shall be deemed to have become &#8220;permanently incapacitated&#8221; on the date that is thirty (30) days after the Company has determined that the Executive has suffered a Permanent Incapacity (as defined below) and so notifies the Executive. For purposes of this section, &#8220;Permanently Incapacitated&#8221; shall mean (i) the Executive&#8217;s actual or anticipated inability, due to physical or mental incapacity, to substantially perform his duties and responsibilities under this Agreement with or without reasonable accommodation for six (6) months out of any twelve (12) month period, or four (4) consecutive months&#59; or (ii) the Executive is receiving income benefits for a period of ninety (90) days under any long-term disability plan by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of four (4) months or more.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Termination by the Company for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may terminate this Agreement and the Executive&#8217;s employment hereunder for Cause (as defined below), effective immediately upon delivery of written notice (the &#8220;Termination Notice&#8221;) to the Executive given at any time during the Term (without any necessity for prior notice).  For purposes of this Agreement, &#8220;Cause&#8221; shall mean the Executive&#8217;s&#58; (1) conviction of any felony or any other crime involving dishonesty or moral turpitude, (2) commission of any act of fraud or dishonesty by the Executive, or theft of or intentional damage to the property of the Company or any of its subsidiaries or affiliates, (3) engaging in any act that has had, or can reasonably be expected to have, a significant adverse financial effect on the Company or a significant adverse effect on the Company&#8217;s reputation, (4) willful or intentional breach of Executive&#8217;s fiduciary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">duties to the Company, (5) breach by Executive of any material provision of this Agreement, or (6) violation of a material policy of the Company as in effect from time-to-time.  Prior to a termination by the Company of the Executive's employment for Cause under subsections (5) or (6) of this Section 11(b), in the event that the Company deems the breach curable in its sole reasonable discretion, the Executive shall first have an opportunity to cure or remedy such breach within fifteen (15) days following the Termination Notice, or such longer period as is reasonable under the circumstances, and provided that Executive diligently pursues such cure within such fifteen (15) day period, and if the same is cured or remedied within such period, such Termination Notice shall become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination by the Company without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may terminate this Agreement and Executive&#8217;s employment hereunder without Cause, upon at least thirty (30) days prior written notice to the Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Termination by the Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive may terminate this Agreement and Executive&#8217;s employment hereunder with Good Reason (as defined below). For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean (i) the material reduction of the Executive&#8217;s title, authority, duties and responsibilities or the assignment to the Executive of duties materially inconsistent with the Executive&#8217;s position or positions with the Company&#59; (ii) a change in the Executive&#8217;s principal work location without Executive&#8217;s consent to a location that is more than 35 miles from the Executive&#8217;s principal work location first established under Section 4 of this Agreement, or (iii) the Company&#8217;s material breach of this Agreement.  Notwithstanding the foregoing, (x) Good Reason shall not be deemed to exist unless notice of termination on account thereof (specifying a termination date thirty (30) days from the date of such notice) is given no later than 60 days after the time at which the event or condition purportedly giving rise to Good Reason first occurs or arises and (y) if there exists (without regard to this clause (y)) an event or condition that constitutes Good Reason, the Company shall have fifteen (15) days from the date notice of such a termination is given to cure such event or condition and, if the Company does so, such event or condition shall not constitute Good Reason hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination by the Executive other than for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive may terminate this Agreement and Executive&#8217;s employment hereunder other than for Good Reason, provided that the Executive gives the Company no less than thirty (30) days prior written notice of such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Definition of Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Agreement, &#8220;Change of Control&#8221; shall mean any of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">any one person, or more than one person acting as a group, acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">any consolidation or merger of the Company into another corporation or entity where the stockholders of the Company,&#160;immediately prior to the consolidation or merger, would not, immediately&#160;after the consolidation or merger, beneficially own, directly or&#160;indirectly, securities representing in the aggregate more than fifty percent&#160;(50%) of the combined voting power of all the outstanding securities of the surviving corporation (or&#160;of its ultimate parent corporation, if any).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">the sale, lease or other transfer of all or substantially all of the Company&#8217;s assets to an independent, unaffiliated third party in a single transaction or a series of related transactions.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">the date that a majority of the members of the Company&#8217;s Board of Directors is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by a majority of the members of the Company&#8217;s Board of Directors prior to the date of the appointment or election.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) &#160;&#160;&#160;&#160;In the event of a Change of Control as defined in 11(f) above, all of Executive&#8217;s stock option grants shall immediately vest in accordance with the terms of the applicable plan and award agreement(s), and the options shall immediately become and remain exercisable for a period of 12 months following the date of occurrence of a Change of Control.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">PAYMENTS UPON TERMINATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of the termination of this Agreement and the Executive&#8217;s employment hereunder, the Executive shall receive the amounts and benefits set forth below so long as the Executive (or the Executive&#8217;s estate or beneficiaries in the case of the death of the Executive) (x) executes a separation agreement and general release and waiver of all claims in a form reasonably satisfactory to the Company (the &#8220;Release&#8221;) and the applicable revocation period with respect to such Release expires without the Executive having revoked any portion of the Release, in each case within thirty (30) days following the date of termination, and (y) does not breach any of the restrictive covenants in this Agreement (collectively, &#8220;Restrictive Covenants&#8221;).  Subject to the foregoing, any payments to be made in accordance with this Section 12 will commence on the first payroll date following the end of the 30-day period described in the preceding sentence.   </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Upon termination of this Agreement and Executive&#8217;s employment hereunder pursuant to Section 11(a) hereof, the Executive (or the Executive&#8217;s estate or beneficiaries in the case of the death of the Executive) (i) shall be entitled to (A) receive any unpaid Base Salary earned and accrued under this Agreement prior to the date of termination (and reimbursement under this Agreement for expenses incurred prior to the date of termination), (B) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant to any insurance plan, benefit plan or retirement plan, (C) a pro rata bonus payment under the Bonus Plan for the year of termination, if applicable, determined by multiplying (I) the bonus payment that the Executive would have received under the Bonus Plan for such year had his employment continued by (II) a fraction, the numerator of which is the number of days employed during such year and the denominator of which is 365, (D) treatment of the Executive&#8217;s stock option grants in accordance with the terms of the applicable plan and award agreement, provided that the portion of the Executive&#8217;s options that were exercisable as of the Effective Date, and the portion of the Executive&#8217;s options that would have become exercisable on the next anniversary of the Effective Date following the date of termination, shall become and remain exercisable for a period of 12 months following the date of termination, and (E) if Executive is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the continuation of the same level of Executive&#8217;s medical and dental insurance benefits for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Executive becomes eligible for medical and dental benefits through another employer, which eligibility must immediately be disclosed by Executive to the Company, and (ii) shall have no further rights to any other compensation or benefits hereunder, or any other rights hereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Upon termination of this Agreement and Executive&#8217;s employment hereunder by the Company for Cause pursuant to Section 11(b) hereof or by Executive other than for Good Reason pursuant to Section 11(e) hereof, the Executive (i) shall be entitled to (A) receive any unpaid Base Salary earned and accrued under this Agreement prior to the date of termination (and reimbursement under this Agreement for expenses incurred prior to the date of termination), and (B) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to any insurance plan, benefit plan or retirement plan, and (C) in the case of the termination of the Executive&#8217;s employment by the Executive other than for Good Reason pursuant to Section 11(e) hereof, treatment of the Executive&#8217;s stock option grants in accordance with the terms of the applicable plan and award agreement, provided that the Executive&#8217;s options (or a portion thereof) that were exercisable as of the date of termination shall remain exercisable for a period of 3 months following the date of termination, and (ii) shall have no further rights to any other compensation or benefits hereunder, or any other rights hereunder.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Upon termination of this Agreement and Executive&#8217;s employment hereunder (x) by the Company without Cause pursuant to Section 11(c) hereof, or (y) by the Executive for Good Reason pursuant to Section 11(d) hereof, the Executive (or the Executive&#8217;s estate or beneficiaries in the case of the death of the Executive following the termination of Executive&#8217;s employment) (i) shall be entitled to (A) receive any unpaid Base Salary and other benefits earned and accrued under this Agreement prior to the date of termination (and reimbursement under this Agreement for expenses incurred prior to the date of termination), (B) a pro rata bonus for the year of termination, determined by multiplying (I) the bonus that Executive would have received under the Bonus Plan for such year had his employment continued by (II) a fraction, the numerator of which is the number of days employment during such year and the denominator of which is 365&#59; (C) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant to any insurance plan, benefit plan or retirement plan, (D) continued payment of his Base Salary for the twelve (12) month period following the date of termination, (E) treatment of Executive&#8217;s option grants in accordance with the terms of the applicable plan and award agreement, provided that the portion of the Executive&#8217;s options that were exercisable as of the date of termination, and the portion of the Executive&#8217;s options that would have become exercisable on the next anniversary of the Effective Date following the date of termination, shall become and remain exercisable for a period of 12 months following the date of termination, and (F) if Executive is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the continuation of the same level of Executive&#8217;s medical and dental insurance benefits for the shorter of (x) the twelve (12) month period following the date of termination, or (y) the time at which Executive becomes eligible for medical and dental benefits through another employer, which eligibility must immediately be disclosed by Executive to the Company, and (ii) shall have no further rights to any other compensation or benefits hereunder, or any other rights hereunder.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Upon the occurrence of a Change in Control as defined Section 11(f) hereof, and Executive&#8217;s termination of employment without cause, or the material diminution of Executive&#8217;s authority, in either case within the six (6) month period immediately subsequent to the occurrence of the Change of Control, in addition to any other rights provided for herein upon a Change of Control, Executive (i) shall be entitled to (A) receive any unpaid Base Salary and other benefits earned and accrued under this Agreement prior to the date of termination (and reimbursement under this Agreement for expenses incurred prior to the date of termination), (B) a pro rata bonus for the year of termination, determined by multiplying (I) the bonus that Executive would have received under the Bonus Plan for such year had his employment continued by (II) a fraction, the numerator of which is the number of days employment during such year and the denominator of which is 365&#59; (C) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant to any insurance plan, benefit plan or retirement plan, (D) continued payment of his Base Salary for the 12-month period following the date of termination, and (E) if Executive is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the continuation of the same level of Executive&#8217;s medical and dental insurance benefits for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Executive becomes eligible for medical and dental benefits through another employer, which eligibility must immediately be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">disclosed by Executive to the Company, and (ii) shall have no further rights to any other compensation or benefits hereunder, or any other rights hereunder.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">RESTRICTIVE COVENANTS.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges and agrees that during the period of his employment with the Company and for the 12-month period following the termination of such employment, regardless of the reason for such termination (the &#8220;Restricted Period&#8221;), he shall not, directly or indirectly&#58; (i) engage in, manage, operate, control, supervise, or participate in the management, operation, control or supervision of any business, entity or division that competes with any business of the Company or any of its subsidiaries (a &#8220;Competitor&#8221;) or serve as an employee, consultant or in any other capacity for a Competitor&#59; (ii) have any ownership or financial interest, directly, or indirectly, in any Competitor including, without limitation, as an individual, partner, shareholder (other than as a shareholder of a publicly-owned corporation in which the Executive owns less than five percent (5%) of the outstanding shares of such corporation), officer, director, employee, principal, agent or consultant&#59; or (iii) serve as a representative of any Competitor.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Solicitation&#59; No-Hire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges and agrees that during the Restricted Period he shall not, directly or indirectly, other than in connection with carrying out his duties hereunder, (i) solicit or induce any employee or consultant of the Company (or any individual who was an employee or consultant of the Company at any time during the 12-month period preceding any such solicitation or inducement) to (A) terminate his or his employment or relationship with the Company, and&#47;or (B) work for the Executive or any Competitor, or (ii) hire, engage or be involved in the process of any business, entity or division in hiring or engaging, any employee or consultant of the Company (or any individual who was an employee or consultant of the Company at any time during the 12-month period preceding any such hiring).  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Non-Solicitation of Clients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges and agrees that during the Restricted Period he shall not, directly or indirectly, solicit, take away or divert, or attempt to solicit, take away or divert, the business or patronage of any client or customer of the Company with the intention or for the purpose of providing services that compete with the services provided by the Company at the time of Executive&#8217;s termination.  </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Non-Disruption.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Executive agrees that during the Restricted Period Executive will not, directly or through others, encourage or assist any person to take any action to solicit, induce, or influence any third party, including any customer, provider of goods or services to the Company, to terminate, divert, interfere with, or diminish in any manner whatsoever his, her, or its business relationship with the Company, even if Executive is not the one to initiate contact with the aforementioned.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disparaging Comments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive agrees not to make critical, negative or disparaging remarks at any time during the Term or thereafter regarding the Company or its management, employees, investors, businesses, agents, or employment practices&#59; provided that nothing in this Section 13(e) shall be deemed to prevent the Executive from responding fully and accurately to any question, inquiry or request for information when required by applicable law or legal process, or to enforce this Agreement.  The Company and its officers and directors shall not make critical, negative or disparaging remarks about the Executive&#59; provided that nothing in this Section 13(e) shall be deemed to prevent the Company or its officers or directors from responding fully and accurately to any question, inquiry or request for information when required by applicable law or legal process, or to enforce this Agreement. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive acknowledges and agrees that the Company&#8217;s business is highly competitive and that the Executive will be involved in and become aware of the Company&#8217;s trade secrets, materials, know-how (whether or not in writing), technology, product information and intellectual property belonging to the Company (&#8220;Trade Secrets&#8221;) and all confidential matters (whether available in written, electronic form or orally) relating to the Company and its business (including without limitation its strategies, models, business and marketing plans, pricing, sales and revenue information, financial performance, etc.), and personal and other confidential information relating to its owners, managers, investors, members, shareholders, executives, and employees (the &#8220;Confidential Information&#8221;), all of which has been developed at great investment of time and resources by the Company so as to engender substantial good will, and all of which are and will remain the exclusive property of the Company.  Therefore, the Executive agrees that during the period of his employment with the Company and at all times thereafter, Executive shall not disclose, shall keep secret, shall retain in strictest confidence and shall not use for his benefit or the benefit of others, except in connection with the business and affairs of the Company, any Trade Secret or Confidential Information.  The foregoing will not prohibit disclosure of Confidential Information as required by law or regulation, including, but not limited to, those of the U.S. Securities And Exchange Commission and the rules of any exchange, quotation system and&#47;or self-regulatory organization on which or with which the Company&#8217;s securities are quoted, listed and&#47;or traded, as the case may be&#59; provided that if the Executive is required to make a disclosure pursuant to the foregoing, he agrees to give the Company prompt written notice thereof and cooperate with the Company&#8217;s efforts to seek a protective order.&#160; Neither the foregoing nor anything else herein shall prohibit Executive from reporting possible violation of federal or state law or regulations to any governmental agency of self-regulatory organization, or making other disclosures that are protected under whistleblower or other provisions of applicable federal or state law or regulations.&#160; Notwithstanding any other provision of this Agreement&#58;  (a) The Executive will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that&#58; (i) is made&#58; (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (B) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (ii) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding &#59; and (b) if the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the Company&#8217;s trade secrets to the Executive&#8217;s attorney and use the trade secret information in the court proceeding if the Executive&#58; (i) files any document containing the trade secret under seal&#59; and (ii) does not disclose the trade secret except pursuant to court order. Executive shall not need the prior authorization of the Company to make any such reports or disclosures and Executive is not required to notify the Company that he has made such reports or disclosures.&#160; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Inventions and Discoveries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive agrees to promptly disclose in writing to the Board all ideas, processes, methods, devices, business concepts, inventions, improvements, discoveries, know-how, and other creative achievements (hereinafter referred to collectively as &#8220;Discoveries&#8221;), whether or not the same or any part thereof is capable of being patented, trademarked, copyrighted, or otherwise protected, which Executive, while employed with the Company, as well as those communicated to Executive by other employees&#47;consultants of the Company, conceives, makes, develops, acquires or reduces to practice, whether acting alone or with others and whether during or after usual working hours, and which are related in any way to the Company&#8217;s business or interests.  Executive hereby transfers and assigns to the Company in perpetuity all right, title and interest in and to such Discoveries, including but not limited to, any and all domestic and foreign copyrights and patent and trademark rights therein and any renewals thereof, all of which are hereby deemed provided to the Company as a &#8220;Work for Hire&#8221; without claim by Executive.  On request of the Company, Executive will, without any additional compensation, whether during the Term or afterwards, execute such further instruments (including, without limitation, applications for copyrights, letters patent, trademarks </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and assignments thereof in any and all countries) and do all such other acts and things as may be deemed necessary or desirable by the Company to protect and&#47;or enforce its right in respect of such Discoveries.  All expenses of filing or prosecuting any patent, trademark or copyright application shall be borne by the Company, but Executive shall cooperate in filing and&#47;or prosecuting any such application.  In the event the Company is unable, after reasonable effort, to obtain Executive&#8217;s signature on any such documents, Executive hereby irrevocably designates and appoints the Company as his agent and attorney-in-fact, to act for and on Executive&#8217;s  behalf solely to execute and file any such application or other document and do all other lawfully permitted acts to further the prosecution and issuance of patents, copyrights, or other intellectual property protection related to the Discoveries with the same legal force and effect as if Executive had executed them. Executive agrees that this power of attorney is coupled with an interest.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;(i) &#160;&#160;&#160;&#160;For purposes of this Agreement, any Discovery shall be deemed to have been made during Executive&#8217;s employment with the Company if, during such period, the Discovery was conceived or first actually reduced to practice, and Executive agrees that any patent application filed by Executive within one (1) year after the end of the Term shall be presumed to relate to an invention made during Executive&#8217;s employment with the Company unless Executive can establish the contrary.  Executive shall keep and maintain adequate and correct written records of all Discoveries made by Executive (solely or jointly with others) during Executive&#8217;s employment with the Company.  The records will be available to and remain the property of the Company at all times.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;(ii)  &#160;&#160;&#160;&#160;Any assignment of copyrights under this Agreement includes all rights of paternity, integrity, disclosure, and withdrawal and any other rights that may be known as &#34;moral rights&#34; (collectively, &#34;Moral Rights&#34;). Executive hereby irrevocably waives, to the extent permitted by applicable law, any and all claims Executive may now or hereafter have in any jurisdiction to any Moral Rights with respect to the Discoveries.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive agrees and acknowledges that each restrictive covenant in this Section 13 is reasonable as to duration, terms and geographical area and that the same is necessary to protect the legitimate interests of the Company, imposes no undue hardship on Executive, and is not injurious to the public.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">INJUNCTIVE RELIEF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive agrees that the precise value of the covenants in Sections 13 are so difficult to evaluate that no accurate measure of liquidated damages could possibly be established and that, in the event of a breach or threatened breach of such provisions, the Company shall be entitled to temporary and permanent injunctive relief (without the position of a bond or other security) restraining Executive from such breach or threatened breach without the requirement of posting a bond or other security. In the event that any of the covenants made in Section 13 shall be more restrictive than permitted by applicable law, the parties agree that such covenant shall be interpreted to be as restrictive as otherwise allowed under applicable law.  Additionally, all time periods described in Sections 13 shall be extended by a period during which Executive is in violation of any provision of this Agreement, and for any time during which there is pending in any court of competent jurisdiction any action (including any appeal from final judgment) brought by any person, whether or not a party to this Agreement, in which the Company seeks to enforce any covenant contained in this Agreement, or in which any person contests the validity or enforceability of any covenant contained in this Agreement, or seeks to avoid performance or enforcement of a covenant contained within this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">INDEMNIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; During and after the period of Executive&#8217;s employment by the Company, the Company shall indemnify the Executive to the maximum extent permitted by any applicable agreement, arrangement or corporate governance document of the Company or, in the event no such agreement, arrangement or document exists, to the maximum extent permitted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">by applicable law, in either case against all liabilities, losses, damages and expenses actually and reasonably incurred by the Executive in connection with any claim or proceeding arising out of, or relating to, his services for the Company, other than (i) any claim or proceeding by the Company against the Executive and (ii) any claim or proceeding by the Executive against the Company (&#8220;Losses&#8221;).  The Company shall advance to the Executive to the extent permitted by law all Losses incurred by him provided the Executive undertakes to repay the amount of such advances if it shall ultimately be determined that he is not entitled to be indemnified against such Losses. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">NOTICES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; Any notice required or permitted to be given pursuant to the provisions of this shall be sufficient if in writing, and if personally delivered to the party to be notified or if sent by registered or certified mail to said party at the following addresses, or such other address as provided by the parties in writing&#58; </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If to the Company&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Apyx Medical Corporation </font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5115 Ulmerton Road </font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Clearwater, FL 33760 </font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attn&#58;  Charles D. Goodwin II</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ruskin Moscou Faltischek, P.C.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1425 RXR Plaza</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;East Tower, 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Uniondale, New York 11556</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attn&#58;  Adam P. Silvers, Esq.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If to the Executive&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Matthew Hill</font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">69 Kingsbridge Drive </font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lumberton, NJ 08048&#160;&#160; </font></div><div style="padding-left:144pt"><font><br></font></div><div style="padding-left:144pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; In the event any portion of this Agreement is held to be invalid or unenforceable, the invalid or unenforceable portion or provision shall not affect any other provision hereof and this Agreement shall be construed and enforced as if the invalid provision had not been included. The parties further agree that a court is expressly authorized to modify any unenforceable provision of this Agreement by making such modifications as it deems warranted to carry out the intent and agreement of the parties hereto, which is to enforce the terms of this Agreement to the maximum extent permitted by law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">BINDING EFFECT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; This Agreement shall inure to the benefit of and shall be binding upon the Company and upon any person, firm or corporation with which the Company may be merged or consolidated or which may acquire all or substantially all of the Company's assets through sale, lease, liquidation or otherwise.  Except as otherwise specifically provided herein, the rights and benefits of Executive are personal to him and no such rights or benefits shall be subject to assignment or transfer by Executive. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; This Agreement shall be construed and interpreted in accordance with the laws of the State of Florida, without regard to its conflict of laws provisions. Any legal proceeding arising out of or relating to this Agreement will be instituted in a state or federal court in Pinellas County, Florida, and the Executive and the Company hereby consent to the personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that they may have to personal jurisdiction, the laying of venue of any such proceeding and any claim or defense of inconvenient forum.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">ENTIRE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; This Agreement constitutes the entire agreement between the parties and merges, integrates and supersedes any prior agreement or discussion in its entirety&#59; and there are no other agreements between the parties with respect to the subject matter contained herein except as set forth herein.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">AMENDMENT AND MODIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; All terms, conditions and provisions of this Agreement shall remain in full force and effect unless modified, changed, altered or amended, in writing, executed by both parties. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">NON-WAIVER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No waiver of any breach of any term or provision of this Agreement shall be construed to be</font><font style="color:#171717;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or shall be</font><font style="color:#171717;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a waiver of any other breach of this Agreement. No waiver shall be binding unless in writing and signed by the party waiving the breach.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">SECTION 280G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in this Agreement to the contrary, in the event that any payment or benefit received or to be received by the Executive (including any payment or benefit received in connection with a Change of Control or the termination of Executive&#8217;s employment, whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement) (all such payments and benefits being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) would not be deductible (in whole or part) by the Company as a result of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, to the extent necessary to make such portion of the Total Payments deductible (and after taking into account any reduction in the Total Payments provided by reason of Section 280G of the Code in any such other plan, arrangement or agreement), the portion of the Total Payments that do not constitute deferred compensation within the meaning of Section 409A of the Code shall first be reduced (if necessary, to zero), and all other Total Payments shall thereafter be reduced (if necessary, to zero), with cash payments being reduced before non-cash payments, and payments to be paid last being reduced first&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such reduction shall only be made if the amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments) is greater than or equal to the amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of the excise tax imposed under Section 4999 of the Code on such unreduced Total Payments).  It is possible that, after the determinations and selections made pursuant to this Section 23, the Executive will receive Total Payments that are, in the aggregate, either more or less than the amount properly determined under this Section 23 (hereafter referred to as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Underpayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, as applicable).  If it is established, pursuant to a final determination of a court or an Internal Revenue Service proceeding that has been finally and conclusively resolved, that an Excess Payment has been made, then Executive shall promptly repay the Excess Payment to the Company, together with interest on the Excess Payment at the applicable federal rate (as defined in Section 1274(d) of the Code) from the date of Executive&#8217;s receipt of such Excess Payment until the date of such repayment. In the event that it is determined by a court or by the accounting firm which was, immediately prior to the Change in Control, the Company's independent auditor, upon request of either party, that an Underpayment has occurred, the Company shall promptly pay an amount equal to the Underpayment to Executive (but in any event within ten (10) days of such determination), together with interest on such amount at the applicable federal rate from the date such amount would have been paid to the Executive had the provisions of this Section 23 not been applied until the date of payment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">SECTION 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement is intended to comply with or be exempt from Section 409A of the Code and will be interpreted, administered and operated in a manner consistent with that intent. Notwithstanding anything herein to the contrary, if at the time of the Executive&#8217;s separation from service with the Company he is a &#8220;specified employee&#8221; as defined in Section 409A of the Code (and the regulations thereunder) and any payments or benefits otherwise payable hereunder as a result of such separation from service are subject to Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is six months following the Executive&#8217;s separation from service with the Company (or the earliest date as is permitted under Section 409A of the Code), and the Company will pay any such delayed amounts in a lump sum at such time. If any other payments of money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under Section 409A of the Code, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Section 409A of the Code, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that does not cause such an accelerated or additional tax. To the extent any reimbursements or in-kind benefits due to the Executive under this Agreement constitute &#8220;deferred compensation&#8221; under Section 409A of the Code, any such reimbursements or in-kind benefits shall be paid to the Executive in a manner consistent with Treas. Reg. Section 1.409A-3(i)(1)(iv). Each payment made under this Agreement shall be designated as a &#8220;separate payment&#8221; within the meaning of Section 409A of the Code.  References to &#8220;termination of employment&#8221; and similar terms used in this Agreement are intended to refer to &#8220;separation from service&#8221; within the meaning of Section 409A of the Code to the extent necessary to comply with Section 409A of the Code. Whenever a payment under this Agreement may be paid within a specified period, the actual date of payment within the specified period shall be within the sole discretion of the Company. In no event may the Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement. Any provision in this Agreement providing for any right of offset or set-off by the Company shall not permit any offset or set-off against payments of &#8220;non-qualified deferred compensation&#8221; for purposes of Section 409A of the Code or other amounts or payments to the extent that such offset or set-off would result in any violation of Section 409A or adverse tax consequences to the Executive under Section 409A.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">SURVIVAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement will survive the cessation of the Executive&#8217;s employment to the extent necessary to fulfill the purposes and intent of this Agreement.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">CAPTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Captions of the sections or paragraphs of this Agreement are intended </font><font style="color:#171717;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">olely for convenience and no provision of this Agreement is to be construed by reference to the caption or heading of any section or paragraph. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt">PREVAILING PARTY.  In the event of an action to remedy a breach of any provision hereof or to enforce the terms of this Agreement by either of the parties, the prevailing party shall be entitled to recover his&#47;its costs and reasonable attorney&#8217;s fees, in addition to all other available remedies...</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive hereby irrevocably agrees to waive his right to a jury trial of any claim or cause of action based upon or arising out of this Agreement or any dealings between the parties relating to this Agreement and the relationships thereby established.  The scope of this waiver is intended to be all-encompassing of any and all disputes that may be filed in any court and that relate to the subject matter of this Agreement, including employment law claims, contract claims, tort claims, breach of duty claims, and all other statutory and common law claims.  This waiver shall apply to any subsequent amendments, renewals, supplements or modifications of this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt;text-decoration:underline">COUNTERPARTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed electronically, by email or facsimile, and in counterparts, and shall be fully binding and enforceable upon the parties when so executed.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">signature page to follow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APYX MEDICAL CORPORATION </font></div><div style="margin-bottom:10pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:42.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Charles D. Goodwin II</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;  November 21, 2023</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  Charles D. Goodwin II</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  Chief Executive Officer </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">BY SIGNING IN THE SPACE PROVIDED, EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS FULLY READ</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT AS OF THE DATE SET FORTH BELOW. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:42.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Matthew Hill</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;  November 21, 2023</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MATTHEW HILL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>cfoappointmentpressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i58f4dc403a694ffe92c366cbee957a06_1"></div><div style="min-height:90pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"><div><img alt="image2a.jpg" src="image2a.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:118px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br></font></td></tr></table></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">CLEARWATER, FL &#8212; November 28, 2023 - Apyx Medical Corporation (Nasdaq&#58;APYX) (&#8220;Apyx Medical&#59;&#8221; the &#8220;Company&#8221;), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion&#174;, today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8220;Matt joins our executive leadership team with over 30 years of financial and operational experience, more than 20 years of which has been in the healthcare industry, where he has served as the Chief Financial Officer of four publicly-traded healthcare companies,&#8221; said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical. &#8220;I&#8217;m pleased to welcome Matt to Apyx Medical and look forward to working with him to execute our strategic initiatives and position the Company to deliver strong, sustainable, long-term growth.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8220;With its innovative Renuvion technology, large, global market opportunity, recent operational progress and an enhanced balance sheet, I believe Apyx Medical is well-positioned for future success in the cosmetic surgery market,&#8221; said Mr. Hill. &#8220;I am pleased to join the Company at this exciting time, and look forward to working with Charlie and the rest of the team as we lead Apyx Medical through its next stage of growth and development.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Mr. Hill joins Apyx Medical from PDS Biotechnology Corporation (Nasdaq&#58; PDSB&#59; &#8220;PDS Biotech&#8221;), a clinical-stage immunotherapy company, where he served as Chief Financial Officer, leading all aspects of the company&#8217;s budgeting, forecasting, financial management and reporting. Prior to joining PDS Biotech, he served as Chief Financial Officer of Strata Skin Sciences (Nasdaq&#58; SSKN), a medical technology company developing, commercializing and marketing products for the treatment of dermatologic conditions, from 2018 to 2021. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Prior to joining Strata Skin Sciences, Mr. Hill held CFO roles at several companies, including Velcera, Inc., which developed pet medication for the companion animal health industry, and EP MedSystems, which developed and marketed cardiac electrophysiology products. He was also a Senior Manager at the international accounting and consulting firm, Grant Thornton LLP. Mr. Hill holds a Bachelor of Science in Accounting from Lehigh University.</font></div><div style="text-align:justify"><font><br></font></div><div id="i58f4dc403a694ffe92c366cbee957a06_10"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">About Apyx Medical Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people&#8217;s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion&#174; in the cosmetic surgery market and J-Plasma&#174; in the hospital surgical market. Renuvion&#174; and J-Plasma&#174; offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">www.ApyxMedical.com.</font></div><div><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement on Forward-Looking Statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#58;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:90pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr style="height:65pt"><td colspan="3" style="padding:0 1pt"><div><img alt="image2a.jpg" src="image2a.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:121px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to, projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items&#59; projections or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality including but not limited to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), supply chain disruptions, component shortages, manufacturing disruptions or logistics challenges&#59; or macroeconomic or geopolitical matters and the impact of those matters on the Company&#8217;s financial performance.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Forward-looking statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company&#8217;s ability to control or predict. Important factors that may cause the Company&#8217;s actual results to differ materially and that could impact the Company and the statements contained in this release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company is subject to, including the Company&#8217;s ability to gain requisite approvals for its products from the FDA and other governmental and regulatory bodies, both domestically and internationally&#59; the impact of the March 14, 2022 FDA Safety Communication on our business and operations&#59; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions&#59; changes in general economic, business or demographic conditions or trends&#59; changes in and effects of the geopolitical environment&#59; liabilities and costs which the Company may incur from pending or threatened litigations, claims, disputes or investigations&#59; and other risks that are described in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and the Company&#8217;s other filings with the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:107%;text-decoration:underline">Investor Relations Contact&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">ICR Westwicke on behalf of Apyx Medical Corporation</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Mike Piccinino, CFA </font></div><div><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">investor.relations&#64;apyxmedical.com</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>apyx-20231121.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8e91d6bb-3e52-44e0-a79f-ce7b8f902cfd,g:5d28ccab-7708-4f10-910c-060a6fbe0eb5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:apyx="http://www.apyxmedical.com/20231121" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.apyxmedical.com/20231121">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="apyx-20231121_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="apyx-20231121_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.apyxmedical.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>apyx-20231121_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8e91d6bb-3e52-44e0-a79f-ce7b8f902cfd,g:5d28ccab-7708-4f10-910c-060a6fbe0eb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_211953b5-2fb5-4031-bf8c-76c257c76e79_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2e91f449-da24-46cd-a83e-d2edd7fc916a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1984f4c3-fa52-4e0c-a05f-af9b25c8e032_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e2494189-49dc-467a-89f2-56174ceed125_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_75c2e8f0-5aa2-48ba-b601-545928c68f16_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c2f6b514-2274-46c3-bd64-789ba3f1a90a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b3e71307-eb52-44ff-b528-b78c71c39ba0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_66659282-61aa-468d-9e9c-bf95c686ff05_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_38495fb6-de55-4800-9aa8-49b2cb622c75_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_eef1d413-83b1-4273-9739-b10ee62d8e9b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_81479c96-ac08-43ea-a2de-0423ac07ba0d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d4878032-18f1-4d9e-989a-e7b8653c42e9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c90ccc0a-28ac-414a-a56d-05ec47212013_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a3ea5c73-a488-49d1-800a-588ca51c9f9f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_daccb67a-8943-4d0a-b13e-03169ba5c6fe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_243f8b4a-5d7d-4bac-b542-656e6631d565_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f6f6a069-709c-43c2-b15e-5a07e33ffde0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_257ae82c-4217-4139-89cc-ea375f14bdba_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a578ef93-503a-4c50-a71d-9e1879e9b276_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_042e6a5f-2ef3-415c-be68-e23905b202cc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3038ba99-beae-4d22-8e21-0a1eb163c5a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_92dfe883-aa91-462a-bc05-d20b401a6b14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b92e4db0-6247-444b-86a1-516e85d690d3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>apyx-20231121_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8e91d6bb-3e52-44e0-a79f-ce7b8f902cfd,g:5d28ccab-7708-4f10-910c-060a6fbe0eb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.apyxmedical.com/role/CoverPage" xlink:type="simple" xlink:href="apyx-20231121.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.apyxmedical.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0b5fe2b7-87e4-456e-9b41-087fb8137229" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_DocumentType_0b5fe2b7-87e4-456e-9b41-087fb8137229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_290c7ce3-0564-47b5-9895-b62df4918775" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_DocumentPeriodEndDate_290c7ce3-0564-47b5-9895-b62df4918775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f092b83-60ce-467d-9bf8-1c14a8c8de2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityRegistrantName_8f092b83-60ce-467d-9bf8-1c14a8c8de2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_88f2b168-1af9-4d0f-a726-fa8d2d90ac88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityAddressAddressLine1_88f2b168-1af9-4d0f-a726-fa8d2d90ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6294b917-dd1f-458f-a3e4-a53a12199cc0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityAddressCityOrTown_6294b917-dd1f-458f-a3e4-a53a12199cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8f751c28-0955-496c-b08e-e0c1c5413a36" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityAddressStateOrProvince_8f751c28-0955-496c-b08e-e0c1c5413a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_347deca4-da54-45fd-8252-06b421d8861a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityAddressPostalZipCode_347deca4-da54-45fd-8252-06b421d8861a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2c5c1de8-ece2-44aa-ac98-18d4bba0b8f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_CityAreaCode_2c5c1de8-ece2-44aa-ac98-18d4bba0b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a1fd6d65-555b-4210-9aa0-ea08bde4ec2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_LocalPhoneNumber_a1fd6d65-555b-4210-9aa0-ea08bde4ec2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9272df4a-1406-44cb-9a3c-94a6d88e32d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_WrittenCommunications_9272df4a-1406-44cb-9a3c-94a6d88e32d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_422afeec-4c23-4305-a5af-4ee6eaf6fa39" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_SolicitingMaterial_422afeec-4c23-4305-a5af-4ee6eaf6fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_44f001fd-ddf9-4233-aa41-c117901bd454" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_PreCommencementTenderOffer_44f001fd-ddf9-4233-aa41-c117901bd454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_b17b20f8-b578-434a-972d-661d0b2e88aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_b17b20f8-b578-434a-972d-661d0b2e88aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_54628be3-4041-4d0a-b2df-d1f6adfb9ac1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityEmergingGrowthCompany_54628be3-4041-4d0a-b2df-d1f6adfb9ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9a2935ad-cb3b-4c41-b882-3ab69e59f24c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityFileNumber_9a2935ad-cb3b-4c41-b882-3ab69e59f24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bc092f7e-3bc4-4238-b68f-95737f0ddb5d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bc092f7e-3bc4-4238-b68f-95737f0ddb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_df036a5e-9017-4139-87f4-fa227f29263a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityTaxIdentificationNumber_df036a5e-9017-4139-87f4-fa227f29263a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c13ea9cf-2d78-4b6b-9705-696c3ad0b6c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_Security12bTitle_c13ea9cf-2d78-4b6b-9705-696c3ad0b6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_251f2eca-be9d-45ba-9d84-f24e56f8ede2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_TradingSymbol_251f2eca-be9d-45ba-9d84-f24e56f8ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_031a76df-bdd1-4b70-83b0-0056a898ef7c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_SecurityExchangeName_031a76df-bdd1-4b70-83b0-0056a898ef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0fb3a4c8-3514-4ec8-bcf5-e1100a4ee772" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_EntityCentralIndexKey_0fb3a4c8-3514-4ec8-bcf5-e1100a4ee772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6cb31633-8b4c-4ff9-9c32-46796b5b3383" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_83a76abe-e08a-4fbb-be3d-e408626064f0" xlink:to="loc_dei_AmendmentFlag_6cb31633-8b4c-4ff9-9c32-46796b5b3383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>apyx-20231121_g1.jpg
<TEXT>
begin 644 apyx-20231121_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1A;BY,:6-K
M=&5I9P    60 P "    %   $*:0!  "    %   $+J2D0 "     S4U  "2
MD@ "     S4U  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJ9]<#%:4_:\WO[&51TG'W-R:BBBN@P"BBB@ HHHH ***:S8&3TH Y;Q[J_\
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M^E_^$U\,_P#0>T__ ,"4_P :T[34K*_C\RRNH;A/[T4@8?I7BK?LZ?*=OB$
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M@'YUA1_B(UJ? S)_9[N&?P=?P,<B.])'ME%JO^T/_P B]I?_ %\-_P"@T_\
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M3NQ/VLE9JQ<^$7AV;PYX"MX[M"EQ=.;F1".5W  #\@*Y;]H?_D7M+_Z^&_\
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M%!/W'='1!R:]X****S+"BBB@ HHHH ***3- "T4F:6@ HHHH **** "BBB@
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MEC$A.>9%SUYKKO\ A6OA'[7]H_L&UWYSC9\N?]WI6W?Z/8ZEI;:=>6T<MHX
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image2a.jpg
<TEXT>
begin 644 image2a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *0 _(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "L;Q5XNTGP5I$NI:S>)9VB< MRSMV5
M5'+'V%/\4^)K#P=X?O=8U*3RK.U3>Y')8YP% [DD@#W-?"'Q(^(^J_$OQ!)J
M.H2,D"DBVLU8F.W3T'N<#+=_R ^7SO.X93348J]26R_5^7YGU>0Y%/.*CE)\
MM..[[^2\_P CU#QW^UEK>JS20>&+=-'L^@N9T66X;WP<JOTPWUKR#5_'7B+7
MG9M1UW4;S/\ #-<N5'?@9P/PK#HK\>Q69XS&R<J]1ORV7W;'[1A,KP6!BHT*
M27GN_O>I=@US4;6020ZA=0R#H\<S C\0:[KPK^T%XX\*R)MUB35+<'FWU+,X
M/_ B=X_!J\XHKFHXO$8>7-1J.+\F=5?!X;$QY*U-27FD?;/PL_:%T+XB216%
MPO\ 8^MMPMK,^4F/_3-^,G_9.#Z9ZUZO7YHQR-%(KHQ1U.593@@CN*^O/V<O
MC2_C2R_X1[6I]^MVL>Z&>0_-=1#U]77C/J.>Q-?J.0\2/&36%Q?QO9]_)^?Y
M_G^4<0<,K!0>+P?P+==O->7XKTV]RHHHK]!/SD**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLWQ%KEMX9T
M&_U:\?;;6<+3/[@#.![GH/<U,I*$7*3LD5&,IR48J[9\S_M;>/#?:U9>%;67
M]Q9J+F[53UE8?(I_W4.?^VGM7SS6AXAURY\3:Y?ZK>-NNKR9II/0%CG ]AT'
MTK/K^=\SQLLPQ<\0]F]/3I^!_265X&.78.GAENEKYOK^(4445YAZ@4444 %:
M7AO7[OPKKUAJ]BYCNK.994.>N#R#[$9!]B:S:*J,I0DI1=FB91C.+A)73/T>
M\.ZY;>)M!L-6LWW6UY"LR>P(S@^XZ'W%:5?/'[(_CK[=HM_X6N),S6)-U:@]
M3$Q^=1_NN0?^VE?0]?T/EF,6882GB%NUKZ]?Q/YNS3 RR[&5,,]D]/1[?@%%
M%%>H>4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?/'[7'CK[#HMAX6MY,37Q%U= =1$I^13_ +S@G_MG7T'/,EM#
M)-*ZQQ1J7=V. H R2:_/OXF>,I/'WCC5=:8MY,TNV!6_AA7Y4&.W !/N37Q?
M%6/^JX+V$7[U33Y=?\OF?<<)9?\ 6\=[>:]VGK\^G^?R.7HHHK\6/W ***.M
M !174^/_ (>ZE\.[W3[;45PUY917:\$;2P^9#_M*P(/X>M<M6M6E.A-TZBLU
MT,J5:G7@JE)WB^H4445D:G4?#/QE)X!\<:5K2EO)AEVSJO\ %"WRN,=^"2/<
M"OT$@F2YACFB=9(I%#HZG(8$9!%?FG7V=^S#XZ_X2KX?IIL\N^^T9A;,">3"
M<F(_D"O_  "OT?@_'\E6>"F]):KU6_WK\C\TXTR_VE*&.@M8Z/T>WW/\SV*B
MBBOU8_(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ&X
MNH;*!YKB6."%!EI)&"JH]23TKS/Q/^TEX&\-EXTU)]8N%_Y9Z;'Y@_[[.$/X
M$UR8C%X?"1YJ\U'U9V8;!XG&2Y</3<GY(]2HKY:\0?MBZA(S+HGA^WMUZ"2^
ME:4GWVKMQ^9KS_6/VC?'^K[A_;?V*,_\L[.!(\?\"QN_6OF*_%F74M(-S]%_
MG8^KP_"&9UM9J,/5_P"5S[EJ*:XBMU#2RI$I. 78#^=?GCJ'CSQ+JV?MOB#5
M+H'M->2,._8GW/YUB22/,Y=V9W/5F.2:\:IQI#_EW0OZRM^C/:I\#S?\3$)>
MD;_JC]&V\3:0K%6U6Q# X(-RF1^M'_"4:-_T%K'_ ,"4_P :_.*BN;_72I_S
MX7_@7_ .C_4>G_T$/_P'_@GZ0PZYIMUGR=0M9L<'RYE;'Y&K]?F?5JSU6]TT
MYM+RXM3ZPRLG\C6L.-/YZ'_DW_ ,Y<#_ ,F(^^/_ -L?I-17Y_Z7\8/&VC$?
M9O$^I8'19YS,H_!\BNWT/]J_QKIK*+X6&KI_$9X/+?\  QE0/R->I1XPP,]*
MD)1^YK\[_@>36X+Q]/6E.,OO3_*WXGV317@'AO\ :_T*^98]:TB[TMSP9+=A
M<1CW/W6'X UZYX6^(?AOQJ@;1=8M;Y\9,*OME ]T;##\J^FPN:8+&Z4*J;[;
M/[GJ?+8O*<=@=<12:7?=?>KHZ.BBBO5/)"BBB@ HHJ.:(3PR1DLH=2I9&*L,
MCL1R#[T@)**^#_&GBCQQX-\5ZIHMQXLU[S+.=HPQU&;YUZJWWNZE3^-8O_"S
M_&7_ $-NN?\ @RF_^*K\_J<84:<W"=&2:=GJNA^C4^"ZU6"J0KQ::NM'U/T*
MHK\]?^%G^,O^AMUS_P &4W_Q5*GQ1\91L&'BS7"0<_-J,Q'Y%JC_ %SP_P#S
MY?WHT_U(Q/\ S^C]S/T)HKXX\ ?M1>)?#MY%%KTG]O:82 ^]56XC'JK@#<?9
MNO3(KZVT'7K'Q-H]KJFF7"W5C<IOCE7N/0CL0<@@]",5]1EF<87-(OV+M);I
M[_\ #'R>:9+BLIDO;J\7LUM_P&:-%%%>X>"%%%% !1110 4444 %%%% !111
M0 4444 %%%% !17(?$KXE:7\,= .HZAF::0E+:TC(#SOCH/0#C+=L]S@'Y+\
M5?M%>-_$UU(T6J-H]J3\EOI_[O:/=_O$_C^ KYS,\^PF5R]G4O*?9?KV/ILJ
MX?QF;1]I3M&'=_IW/N.BOSU_X6?XR_Z&W7/_  93?_%4?\+/\9?]#;KG_@RF
M_P#BJ^=_USP__/E_>CZ3_4C$?\_H_<S]"J*_/7_A9_C+_H;=<_\ !E-_\57O
M7[*\_B3Q1J&K:UJ^NZIJ&GVJ"UBANKR22-I6PS'#,1E5 _[[KT,!Q-3S#$1P
MU.D[OS6AYV8<*U,NPTL34K)J/2SU/I"BBO%/VD/#_B6+1E\2>&M;U6R-FF+V
MSL[R6-&B_P">H56QE>_'3G^&OI\;B982A*O&#ERZV6]O^ ?*X'#1QF(C0E-0
MYM+O:_3[SVNBOSU_X6?XR_Z&W7/_  93?_%4?\+/\9?]#;KG_@RF_P#BJ^(_
MUSP__/E_>C[O_4C$?\_H_<S]"J*_/7_A9_C+_H;=<_\ !E-_\51_PM#QE_T-
MNN?^#&;_ .*H_P!<\/\ \^7]Z#_4C$?\_H_<S]"J*^)_!O[2OC'PQ=Q_;KS^
MWK'(WV][C?C_ &9 -P/UR/:OK?P+XXTOXA>'8-8TJ0M!(2KQR8$D+CJC#L1Q
M]001P:^ERS/,+FEXTKJ2Z/?Y=SY?-<AQ>4VE62<7U6WH^QT-%%%?0'SH4444
M %%%% !1110 4444 %%%% !117C?QL_: M_AO*VCZ5#'?Z^R!G\P_NK8$9&X
M#DL1R%XX()/0'BQF,HX&DZ]>5HK^K([L'@J^85E0P\;R?]7?D>R45\"ZQ\;/
M'.M3M+/XFU" DY"V<QMU'L!'BL__ (6?XR_Z&W7/_!E-_P#%5\5+C/#7]VE)
MKY'W4>",4U[U:*?S/T*HK\]?^%G^,O\ H;=<_P#!E-_\51_PL_QE_P!#;KG_
M (,IO_BJC_7/#_\ /E_>BO\ 4C$?\_H_<S]"J*_/W3_'WCK5KZWLK3Q-K]Q=
M7$BQ11)J,Q9V)P /F]:^V_AWX9O_  IX5M+'5-4N]8U(CS;FZN[AYCYA RJE
MCD*,8 ]L]2:]_*<[6;3DJ=)I1W;?X'SV<9$\GA%U*JE*6R2U]3IZ**^:/&WP
MI\>>#?"NI:V_Q.U>Z6RB,IA6XG4OR!C/FG'6O3QV+JX.'/"DYK5NS2M;U_3L
M>7E^#I8V?LZE90=TE=-W;]/U[GTO17R_\._AOX[^('@[3]?C^)>KV27GF8@:
MXG<KLD9.OFCKMST[UT?[3FMZUX2\'^&4T_6;ZSN?-,4UQ:W#Q--B,<L5.3SS
MS7G+.)K!RQM2@XP236JU3]/U/2>2PEC88&E74IMM/1KE:[WW^1[[17$?!WQX
MOQ$\!V&ILP-]&/L]XH[3*!D_\"&&_P"!5YS^U'\4KOPQ9V'A_1K^:QU*Y/VF
MXGM93')'$"0JAE.1N;/X+[UVXC-*&'P7UYN\6DUYWV1PX;*L1B,=]02M--I^
M5MW_ %N>^T5\T>'?%FN3>']+DDUK4))'M8F9FNG))*#))SUHKBCG=.45+D>I
MWRR&I&3CSK0^EZ***^D/EPHHHH **** "BBB@ HHHH **** /'?VGO'7_"*_
M#]]-@EV7VLL;90#R(1@RG\B%_P"!U\8UZ5^T%XX_X3?XCWS0R^9I^G_Z%;;3
MP0I.]O?+;N?0+7FM?@W$&/\ K^/G*+]V/NKY=?FS^@N'<O\ [/R^$9+WI>\_
MGLODK?,****^;/I@KTG]GWP-_P )Q\1K%9H_,T_3_P#3;G(X(4C8OOEMO'H&
MKS:OL_\ 9A\#?\(K\/TU*>+9?:RPN&)'(A'$0_(EO^!U])P_@?K^/A&2]V/O
M/Y=/F_P/F>(LP_L_+YRB_>E[J^>[^2_$/VGO W_"5?#]]2@BWWVC,;A2!R83
MQ*/R ;_@%?&%?I7/!'=020RHLL4BE'1AD,I&""/3%?GY\3/!LG@'QQJNBN#Y
M4,NZW8\[H6^9#GN=I /N#7T?&& Y*L,;!:2T?JMOO7Y'S7!>8>TI3P,WK'5>
MCW^Y_F<O1117YP?I85Z5^S[XX_X0CXCV+32^7I^H?Z%<[CP Q&QO;#;>?0M7
MFM'2NK"XB>$KPKT]XNYRXK#0QE">'J;25C],**X/X)^./^$^^'NFW\L@DOH1
M]EN_7S4 &X_[PVM_P*N\K^B\/7AB:4:U/:23^\_FG$4)X6M.A46L6T_D%%%%
M=!SA1110 4444 %%%% !1110 4444 %%%% !117FWQ9^-VC_  OMS;G&H:Y(
MN8K"-L;<]&D/\*^W4]O4<V(Q-'"4W6KRY8HZL-A:V,JJC0CS29W>L:U8>']/
MEOM2O(;&TB&7FG<*H]LGO[=Z^?/B!^UM!;M+9^$K(73#C^T;P$)]4CX)^K$?
M0UX-XY^(VN_$34C=ZS>-*%),5LGRPPCT5>WUZGN37,U^59GQ97K-T\$N2/?[
M3_R_/S/UO*^$,/ATJF.?/+M]E?Y_EY&]XJ\>>(/&USYVMZK<7_.Y8W;$:'_9
M085?P%8-%%?"5*DZLG.HVV^KU/OZ=.%&*A3BDET6B"BBBLS0**** "BBB@ H
MHHH **** "GPS/;R+)$[1R*<JZ'!!]0:910!ZUX%_:6\6^$6C@OIQX@L%/,=
MZQ,H'^S+U_[ZW?2OI;X=?&[PS\2%6&RN39ZGC)T^[PLGOMYPX^G/J!7P?3HY
M'AD61&9)%(974X((Y!!KZO+N),;@6HS?/#L_T>_YKR/DLRX9P.8)RA'V<^ZV
M^:V?X/S/TNHKY0^$?[4%YH[P:7XN>2_L.%34L%IH>WS_ -]??[W7[W2OJ?3[
M^VU2SAN[.>.ZM9E#QS0L&1U/0@CK7ZWEN:8;-*?/0>JW3W7]=S\=S/*<5E53
MDKK1[-;/^NQ8HHHKUSQCY?\ VO/!/DWFE^*;>/Y)A]BNB.FX9:-OQ&X?\!6O
MF^OT*^)'@^/QWX)U;17"^9<0DPNW195^9#_WT!GVS7Y\30R6TTD,J-'+&Q1T
M88*D'!!K\8XKP/U;&^WBO=J:_-;_ */YG[?PCC_K6!^KR?O4]/D]OU7R&444
M5\2?<A7TA^R'XX:.\U/PK<RDQR+]LM%8]&&!(H^HVG'^RWK7S?6UX+\33^#?
M%6EZU;@F2RG60J.-Z]&7\5)'XUZV58UY?C*=?HGKZ/<\C-L"LQP53#]6M/5;
M'Z+456T^^@U2QMKVVD$MM<Q+-%(.C(P!4_B"*LU_0R:DKH_F]IQ=F%%%%,04
M444 %%%% !1110 4444 %%%% !117&?%[QH/ 7P_U;54<)=^7Y-KZF9^%(]<
M<M]%-85ZT,/2E6J;13;^1O0HSQ%6-&FM9-)?,^3_ -H;QP?&GQ(OEBEWZ?II
M-E;@?=^4_.WXOGGN M>94I)8DDY)Y.:2OYSQ6(GBZ\Z]3>3N?TOA<-#!T(8>
MGM%6_P"#\PHHHKE.H4 L0 ,D\#%??OPD\&#P'\/])TID"W2Q^==>IF?YF'OC
M.WZ**^3?V>/!?_"9?$RP,J;K+3O].GXX.PC8OXN5X] :^Y*_4N#L#:-3&R6_
MNK]?T^YGY1QKC^:5/ P>WO/\E^OWH*9)&DT;QR(KQL"K*PR"#U!%/HK]+/RX
M^'OCU\*7^&OBDRV<;?V%?DR6C=1$>K1$^W;U!'4@UYA7Z&^/_!%C\0O"UYHM
M^-J2C=%,!EH9!G:X^A_,$CO7P-XF\.7WA'7KW2-2B\F\M9#&X['T8>H(P0>X
M-?B/$>4?V?7]K27[N>WD^W^7_ /W;AG.?[2P_L:K_>PW\UW_ ,_/U,NBBBOD
M#[(*](^!OQ4D^&?BI#<NQT2](BO(QSM_NR@>JY_$$CTKS>BNG#8FIA*T:])V
ME$Y<5AJ6,HRH5E>,E8_2R">.ZACFA=98I%#I(IR&4C((/IBI*^;OV6_BX;F)
M?!NJS9EC!;3I7/WE')A_#DK[9'85](U_0.6X^GF6&CB*?7==GU1_.V9Y?5RS
M$RP]7IL^ZZ/^NH4445Z9Y04444 %%%% !1110 4456U#4+;2K&XO+N9+>UMX
MVEEFD.%10,DG\*3:BKL:3D[(Y+XM?$BV^&/A&?4I-LM_+F*RMV_Y:2D<$_[*
M]3],=2*^#M2U*YU?4+F^O)FN+NXD:665SDLQ.2:Z_P",'Q+N/B=XNFOR7CTV
M',-E;L?N1Y^\1_>8\G\!V%</7X9Q!FSS/$VIO]W'1>?=_/IY'[YP[DZRO#<U
M1?O)ZOR[+Y=?/Y!1117RQ]6%%%>E_ GX5O\ $OQ4IND8:'8E9+Q^F_\ NQ#W
M;'/H ?:NG"X:IC*T:%)7E(Y<5B:6#HRQ%9VC%7/6/V6_A+]AME\9:K#_ *1,
MI73HW'W(SP9?JW0>V3W%?1M1QQI!&D<:+'&@"JBC 4#@ #M4E?T%EV!IY=AH
MX>GTW?=]6?SKF685<SQ,L15Z[+LNB_KJ%<-\</\ DDOB?_KT/\Q7<UPWQP_Y
M)+XG_P"O0_S%7C_]TK?X9?DS/+O]]H_XH_FC,_9M_P"2*^'?^WG_ -*9:X[]
MK0!M+\)@C(.HG(_X"*[']FW_ )(KX=_[>?\ TIEKC_VM/^0;X2_[")_]!%?-
MXK_DG8_X(?\ MI]1A/\ DI9?]?*G_MQC:+?0_L\?&35-,O','A+6HC=0/_#$
M1N90/H=T>.I!0FN(U32[GQYX)^(/Q*U6(AII8;;3XVY\M?M$0)'^ZFU >^7K
MZ9^)7PIT7XIV-G;ZLUS ;60R13VC*L@R,,N65A@X!Z?PBN2^-7AVR\(_L[ZI
MH^G(R6=G':Q1[B"S?Z3$2QQW)R3QU)KBQF4UJ=*O&37L(1G*"\W';TCJUZG;
M@<WHU:M"44_K%25.,W_=4EKZR5D_0\T\+_\ (M:3_P!>D/\ Z **/"__ "+6
MD_\ 7I#_ .@"BO-I?PX^B/6K?Q)>K/JNBBBOU(_) HHHH **** "BBB@ HHH
MH *X+XV>.?\ A ?AYJ-_%)LOIQ]EM.>?-<$9'^Z-S?\  :[VOC[]JSQS_;_C
M2'0K>3=9Z0F)-IX:=P"W_?(VCV.ZOG\^QW]GX&=2+]YZ+U?^2U/H^'\O_M''
MPIR7NQ]Y^B_S=D>(=:***_ C^A0HHHH ZCX9^#9/'WCC2M%0'RII=UPPXVPK
M\SG/8[00/<BOT#@@CM8(X8D6**-0B(HP%4#  'IBOGW]D;P/]AT74/%-Q'B:
M])M;4D=(E.78>Q8 ?]LZ^AZ_:>%<#]5P7MI+WJFORZ?Y_,_#^+<P^MX[V$7[
MM/3Y]?\ +Y!7SQ^USX'^W:+I_BFWCS-9$6MT0.L3'*,?8,2/^VE?0]9OB/0K
M;Q-H-_I-XNZVO(6A?U (QD>XZCW%?09G@UF&$J8=[M:>O3\3YS*\=++L93Q*
MV3U]'O\ @?G#16AX@T.Y\-:Y?Z5>+MNK.9X)/0E3C(]CU!]#6?7\\2BX2<9*
MS1_2,9*<5*+NF%%%%24>W_LI^.?[ \:3:%<2;;/5TQ'N/"SH"5_[Z&X>YVU]
M@U^:^GWT^EW]M>6LAAN;>198I%ZJRG(/YBOT*\#>*H/&WA/2];M\!+N$.R*?
MN..'7\&!'X5^M<(8_P!I0E@YO6&J]'O]S_,_'^,\O]E7AC8+2>C]5M]Z_(WJ
M***_0S\W"BBB@ HHHH **** "BBB@ HHHH ***X+XR?$Z#X7^$I+P;9-3N28
M;&!OXGQRQ']U1R?P'>N?$5Z>%I2K57:,=6=&'P]3%5HT**O*3LCFOCM\=(OA
MU:G2=(:.X\13+SGYEM$(X=AW8\84_4\8!^.+Z^N-2O)KN[GDN;F9B\DTK%F=
MCU))ZT[4M2NM8U"XOKV=[F[N',DLTARSL3DDU6K\'S;-JV:UN>>D%LNW_![G
M]!9/D]'**')#6;^)]_\ @=@HHHKPCW@HHHH ***LZ?IMYJURMO8VL][<-TAM
MXS(Y_ #--)R=D)M15V]"M17HNC_L]^/M:4/'H$MK&?XKV1(<?\!8[OTKK]/_
M &0O%=P UWJ>DV@]%DDD8?AL _6O7I9/F%;6%"7W6_.QX];.LNH:3KQ^^_Y7
M/"Z*^C8/V-;UMGG>*((^?F\NS9L?3+C-6)/V,G6,F/Q<K/V#:=@?GYIKM7#>
M:M7]C^,?\S@?$^4)V]O_ .2R_P CYJHKZ&NOV.=70?Z-XBLICC_EM \?.?8M
M7-ZI^RGXYL%)@33]2Q_#;76TG_OX%K"ID.9TU>5!_+7\KG13X@RNKI&NOGI^
M=CQVBNG\0?#'Q9X75GU/P_?VT2]9A"7C'U=<K^M<Q7C5*-2C+EJ1<7YJQ[=.
MM3K1YJ4E)>3N%%%%9&H4444 %>F_!GXVZA\,=06VG,EYX>F?,]IG)C)ZR1^A
M]1T/Y$>945U87%5<'55:A*TD<N*PM'&TI4*\;Q?]?>?I'H^KVFO:7;:CI]PE
MU9W*"2*:,\,I_P ].U7:^-OV=?C$W@?6ET/5)_\ B0W\@"LYXM93P']E/ ;T
MX/8Y^R:_>,HS2GFN'56.DEI)=G_D^A_/^<Y54RG$NE+6+UB^Z_S74*^*OVFO
M!/\ PBOQ&FO88]ECK"_:T(& ),XE'UW8;_@8K[5KR?\ :4\%?\)9\-[JYAC#
M7NDG[9&<<F,#]XO_ 'S\WU05Q\18'Z[@)\J]Z'O+Y;_@=G#6/^HYC#F?NS]U
M_/;\;?*Y\3T445^$G[\%%%% 'V+^ROXU_P"$@\!OH\\FZ[T>3RU!/)A;)0_@
M=R_0"O:Z^&/V??&W_"%_$K3WE?98ZA_H-QD\ .1M;\'"\^F:^YZ_<N&<=]<P
M$8R?O0]U_I^&GR/P;BC ?4LPE**]VI[R]>OXZ_,****^K/D HHHH **** "B
MBB@ HHHH **** "OE']KGQM_:'B#3_#-O)F'3T^T7('0S./E!_W4Y_[:&OJ#
M6M6MM T>]U*\?R[6TA:>5O15&3CWXK\[_$NO7/BCQ!J.KW9S<7L[3.,Y"Y.0
MH]@, >PKX+B['>QPL<+%ZS>OHO\ -V_$_0N#<![?%RQ<EI36GJ_\E?\  S:*
M**_'S]F"BBMOP5X8G\9^*]+T2WR)+R=8RP_@3J[?@H)_"KITY59J$%=MV7S(
MJ5(TH.I-V25WZ(^K/V5_!9\.^ 7U:9-MWK$GFC(Y$*Y$8_'YV^C"O::KV-C#
MIMC;V=L@BM[>-8HD'154  ?D*L5_1F!PL<%AJ>'C]E?CU?S9_-./Q<L=BJF)
ME]I_AT7R04445W' %>*?M)?"3_A--!_M[3(=VMZ=&=Z(,M<0#DK[LO)'XCN*
M]KHKAQN#I8^A+#U5H_P\_D=^!QM7+\1'$47K'\5U3]3\SZ*]I_:2^$O_  A>
MO?V[ID&W1-1<ED1?EMYCR5]E;DC\1V%>+5_/N-P=7 UY8>JM5^/G\S^B\#C*
M688>.)HO27X=T_0****XCN)K*\GTZ\@N[65H+F!UEBE0X9&!R"#Z@BONSX-?
M$^#XG^$X[MBL>JVV(KZ!?X7QPX']UNH_$=J^#:Z_X6_$2[^&GBVVU6#=);-^
MZN[<'B6(GD?4=0?4>F:^FR'-GE>)]]_NY:2_S^7Y'R_$&3K-L-[B_>1UC_E\
M_P S] :*I:/K%IK^EVNHV$RW%G=1B6*1>A4C]#[=JNU^ZQDI)2B[IGX#*+BW
M&2LT%%%%42%%%% !1110 5\N?M2?%HWEPW@W2IOW$)#:E(A^^XY6+Z#@GWP.
MQKUKXY?%2/X9^%&:W=3K=\&BLXSSM_O2$>BY_$D>]?#<TTEQ,\LKM)*[%G=C
MDL2<DD^M?G7%6;^RA]0HOWG\7DNWSZ^7J?I?"63>VG_:%=>['X?-]_ET\_09
M1117Y.?KH4444 :7ASP_?>*M<L])TZ(S7MW((XU[>Y)[ #))[ &OOCX>>!;'
MX=^%;31K$;O+&^:;&#-*?O.?Z>@ ':O-?V:/A+_PB.A_\)%J<.W6-2C'E1N.
M;> X('LS<$^@P..:]PK]EX9RCZG1^M5E^\G^"_S?4_$^*LY^O5_JE%_NX/7S
M?^2V7S"BBBON#X,*KWUA;:I:RVMY;Q7=M*NV2&= Z./0J>"*L44FDU9C3<7=
M%33=+L]&LXK/3[2"QM(\[+>VC6.-<DDX50 ,DD_4U#JWA_2]?6)=4TVSU)86
MWQK=P)*$;U7<#@_2M&BH]G%QY&M.W0I5)J7.GKWZA534M+L]9LY;/4+2"^M)
M,;[>YC62-L$$95@0<$ _45;HJY14E9[$QDXM-.S1DQ>$]#AC2./1=/CC0!51
M;5 % Z #'2BM:BL_94_Y5]QK[:I_,_O"BBBM3$**** "BBB@ HHHH **** ,
M'QSXJ@\$^$]4UNXP4M(2ZHQ^^YX1?Q8@?C7YZZA?3ZI?W-Y=2&:YN)&EED;J
MS,<D_F:^C/VO/'&Z33/"EM)D+_IMWM/?D1J?PW,1[J:^:Z_&>+,?]8QBP\7[
MM/\ -[_=HOO/VWA#+_JN#>)FO>J?DMOOU?W!1117Q!]V%:'A_0[GQ+KEAI5F
MNZZO)D@C] 6.,GV'4GT%9]?0?[(_@;[?KE_XHN(\PV*FVM6;_GLP^=A]$./^
MVE>GEF#EF&+IX==7KZ=?P/+S3'1R[!U,2]TM/7I^)]-^'-"MO#.@V&DV:[;:
MSA6%/4@#&3[GJ?<UI445_1$8J$5&*LD?S;*4IR<Y.[844451)\I?M<>!OL&N
M6'BBWCQ#?*+:Z9?^>RCY&/U08_[9U\^5^@OQ/\&Q^/O ^JZ,54SS1;[=F_AF
M7E#GMR,'V)K\_9H7MYGBE0QR1L596&""#@@_C7XKQ5@?JN-]M%>[4U^?7_/Y
MG[CPEF'UO ^PD_>IZ?+I_E\AE%%%?&'VX5]*?LA^.-LFI^%+F3 ;_3;3<>_
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MVX9RCZ]6^LUE^[A^+[?+=_<?#<49S]0H?5J+_>3_  7?U>R^;->BBBOV<_$
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MK\\/$WA^Y\*^(-1TB['^D64[0L<8#8/##V(P1[&OR+B_ ^RQ$<7%:3T?JO\
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MR/R+C3'^TK0P47I'5^KV^Y?F%%%%?HI^:!1110 4444 %%%% !1110 4444
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M^G*+BY Z&9Q\H/\ NH?_ !\^E?3GB;Q!;>%?#^H:O>'%M9PM,PZ%L#A1[DX
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M\[****_FD_J **** /H[]C7_ )"7BG_KC;_^A25]15\N_L:_\A+Q3_UQM_\
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M6C7I.THO^OO.7%86GC*$\/65XR5OZ]#]+E99%5E(96&00<@BG5X+^R[\5/\
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MYJZ:L_F:4ZDJ,XU(.S3NO5'YJ7=K-8W4UM<1F*XA=HY(VZJP."#]"*BKV/\
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M<![#"O%36L]O1?YO]#\8XQS#ZQBHX2#]VGO_ (G_ )*WXA1117WI^?!1110
MUF"*68@*!DD]!7XE?M6_&)OCC\<?$/B**4R:3')]@TL9.!:Q$A&&>F\[I,=C
M(:_27]OCXR_\*F^ FI6EI/Y6N>)2=)M-K89(V7]_(._$>5R.C2(:_'ZOJ\EP
M]E*O+T7ZG@9E6NU27JPHHHKZ@\,**** "OV(_80^,O\ PMWX":7'>3^;KGAX
MC2;W<V6=44>3(<\G='M!)ZLCU^.]?3?_  3Y^,P^%GQVM=*O9_*T3Q0JZ9<;
MCA4GSFW<_P# R4]A*3VKR<SP_M\.[;QU._!5O95E?9Z'Z\4445\$?6!1110
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MC"/#3?O4_P GM]SO^!^+<89?]7Q:Q4%[M3?_ !+?[U9_>7****^Z/@ HHHH
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M/X/HG_H6?05X'7XYQ1FWUNO]4I/W(;^<O^!M]Y^U<*91]3H?6ZR]^:T\H_\
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M*^8/J0KW#]F/XJ?\(KX@_P"$<U&;;I.IR#R6<\0W!P ?8-PI]]OO7A]'2N_
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M,_9.#<O]CAI8R:UGHO1?YO\ )!1117Y^?H@5);V\EW<100HTLTC!$11DLQ.
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MK[B/[/H=F?EG_P .LOBO_P!#!X-_\#;O_P"1:/\ AUE\5_\ H8/!O_@;=_\
MR+7ZF44?VOBNZ^X/[/H=F?EG_P .LOBO_P!#!X-_\#;O_P"1:=#_ ,$N/BW;
M31S0^)/!\4L;!TD2^NPRL#D$$6W!!K]2J*/[7Q7=?<']GT.S,3P7#KEOX1T:
M'Q-):3>(8[2-+^6Q=F@DG"@.Z%E4X)!."!C.*VZ**\9N[N>BM%8****0PHHH
MH ^,?VH/ W_"+_$!M3@CVV.LJ;@8' F&!*/Q)#?\#->.U]S_ !_\#?\ "<?#
MF_2&/??V'^FVV!DDJ#N7\5W#'KBOABOPSB7 _4L=*45[L_>7ZK[_ ,S][X8S
M#Z]E\8R?O4_=?Z/[OQ3"BBBOE3ZT*^MOV3?'/]L>%;OPY<R[KK2V\R ,>3 Y
MS@?[K9_!E%?)-=E\(?&S?#_Q]I>J,Y6SW^1=@=X7X;/KCAOJHKWLCQW]GXZ%
M5OW7H_1_Y;_(^?SW+_[2P$Z27O+6/JO\]OF??U%-5ED564AE89!!R"*=7[^?
MSN%%%% 'YZ_$_P#Y*5XM_P"PO=_^CGKF:Z;XG_\ )2O%O_87N_\ T<]<S7\U
MXK_>*GJ_S/Z>PO\ N]/_  K\D%%%%<QU!6WX,\8:CX%\16NLZ7+LN8&Y5ON2
M*?O(P[@C_'K6)15TZDJ4U.#LUJF14IPJP=.HKIZ-'Z!_#?XD:3\3-!74--DV
MS( MU:,?G@<CH?4=<-T./J!UM?G+X7\5ZKX,UB+4]'O)+.[CXW)]UU[JPZ,I
M]#Z5]5_#7]J'0_$T<5GXAV:#J?"^:Q/V64^H8_<^C<?[1K]BR?B:ABXJEBVH
M5._1_P"3\ON/Q?.N%J^#DZV#3G3[=5_FO/[^Y[?14<4T=Q&DL3K)&XW*Z'((
M/0@]ZDK[@^""BBB@ HHHH **** "BBB@ HK-UWQ#IGAG3WOM6OH-/M%ZRW#A
M03Z#U/L.:^;/BI^U5-J$<VF^#E>U@;*MJDJXD8?],U_A_P!X\^P->1F&:X7+
M8<U>6O1+=_+]=CV<NRC%YI/EH1TZM[+Y_HM3M_C]\=8?!=C/H.AW"R^()UVR
M31G(LU/4D_\ /3T';J>V?CYF+L6))8G))[TLLKSR/)([22.2S.QR6)ZDGN:;
M7XGFN:5LUK^UJ:);+LO\^[/W3*<IHY10]E3U;W?=_P"79!1117BGMA3HXVFD
M6-%+NQ"JJC))/04VO4_V;_ [>,/B/:7$J;K#2<7LQ(X+ _NU_%L'W"FNO"8:
M>,KPP\-Y.W]>AR8S%0P>'GB)[15_^!\]CZ^\!^'1X1\&Z-HX"A[.UCCDV]#)
MC+G\6)/XUOT45_1U.G&E!4X[)6^X_F:I4E5G*I/=N[^84445H9A1110 4444
M %?/?[7/@K^T- T_Q-;QYFL'^S7)'_/%S\I/L'X_[:5]"5E^)M MO%7A_4-(
MNQFWO(&A8XR5R.&'N#@CW%>9F>#6/PE3#O=K3UW7XGJY7C7E^,IXE;)Z^FS_
M  /SCHJ[K6D7/A_6+W3+Q-EU9S/!(O\ M*2#CVXJE7\[RBXMQENC^D8R4DI1
M=TPHHHJ2@HHHH ***[[X&^"QXY^)&EV<L?F65NWVRZ!&1Y:$'!]F;:O_  *N
MC#T)XFM"C#>32^\Y\37AA:,Z]3:*;^X^M/@?X*_X07X<:79R1[+VX7[9=9&#
MYC@'!]U7:O\ P&N^HHK^C</0AAJ,*-/:*2^X_FC$UYXJM.O4WDV_O"BBBN@Y
M@HHHH **** "BBB@ HHHH **** "O-/CO\4%^&OA%C;./[:O]T-FO&4X^:4C
MT4'\R*[_ %;5;30]-NM0OIEM[.VC:661^BJ!DU\#_%#X@77Q(\7W>KS[D@)\
MNU@8Y\F$'Y5^O4GW)KY+B+-O[.PW)3?[R>B\EU?^7GZ'V'#64?VEBO:55^[A
MJ_-]%_GY>IRKNTCL[L6=CDLQR2:;117X>?O 4444 *JEV"@$L3@ =Z^WO@#\
M+A\.?"*R7<0&MZB%FNB1S&,?+%_P')S[D^@KQ/\ 9@^%O_"3Z^?$NH0[M,TR
M0>0K=);@8(_!.#]2OO7U[7ZGPGE/)'Z_56KTCZ=7\]EY7[GY/QAF_/+^SJ+T
M6LO7HOEN_.W8****_2C\O"BBB@ KY2_:H^%O]DZD/%VG0XM+Q@E\J#A)CTD^
MC=_]H?[5?5M9^O:'9^)-'O-+U"(3V=W$T4J'T(ZCT(Z@]B :\?-LOAF>%E0E
MONGV?]:,]K*,RGE>+C7CMLUW7]:KS/S?HKI/B'X(O/A[XLOM%O,MY+;H9L8$
ML1^XX^HZ^A!':N;K^?JM.=&<J=16:=F?T32JPK4XU:;O&2NGY!11169J=+\.
M_'%Y\._%EEK5GE_*.V:'.!-$?O(?KV]" >U??>A:U9^)-'L]4T^83V=W&)8I
M!W!['T(Z$=B#7YOU]!?LL_%3^Q]4_P"$1U&7%G>N7LG<\1S'K']&[?[7^]7W
M?"V;?5:WU2J_<GMY2_X.WK8^ XLRCZY0^N45[\%KYQ_X&_I<^KJ***_8C\6"
MBBB@ HHHH **** "BBB@ HHHH *:S+&K,Q"JHR23@ 4ZO*OVC_'1\&_#FY@@
MDV7^JDV<.#\P4C]XWX+QGL6%<F+Q,,'0GB)[15_Z]3LP>%GC<1##T]Y.W_!^
M6Y\K?%[QLWQ \?:IJBN6L]_D6@/:%.%QZ9Y;ZL:XVBBOYSKUIXBK*M4WDVW\
MS^E:%&&'I1HTU:,4DOD%%%%8FX5]S_L_^!O^$'^'-BDT>S4+_P#TVYR.07 V
MJ?HNT8]<U\J_ _P/_P )[\1--LI4WV-N?M=WQD>6A!VGV9MJ_P# J^\Z_3>#
M\!K/&S7]U?J_R7WGY;QIF%E# P?]Z7Z+\W]P4445^H'Y2%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?!GQP\#_\ "!?$34K*)-EC<'[7
M:<8'EN2=H]E;<O\ P&OO.O$?VJO W_"0>"8M;MTW7FCN6; Y:!\!_P CM;V
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MWK#[DW#!6!"0GYG<WN"M>WU7L;&#3;*WL[:,16]O&L44:]%50 !^ %6*_HK
M82.!PT,/'[*_'J_FS^:\PQDL?BJF)G]I_AT7R04445WGGA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !5>^L8-2LKBSN8Q+;W$;12QMT96
M!!'X@U8HI-)JS&FXNZ/SM\>>%)_!'B_5=$GR3:3%$<_QQGE&_%2#^-8-?3G[
M7G@?S(--\5VZ?-'_ *%=D?W228V/T.X?BM?,=?SWF^!>7XV=#INO1[?Y']'9
M/CUF6!IXCKL_5;_Y_,****\<]D<CM&ZNC%74Y#*<$&OOWX2^-E^('@/2]6+
MW13R;I1VF7AOSX8>S"O@"O?/V2_'/]E>)KSPU<R8MM33S;<'H)T&2/\ @29_
M[X K['A?'_5,<J4G[M33Y]/\OF?%\69?]<P#K17O4]?EU_S^1]:4445^V'X6
M?GK\3_\ DI7BW_L+W?\ Z.>N9KIOB?\ \E*\6_\ 87N__1SUS-?S7BO]XJ>K
M_,_I["_[O3_PK\D%%%%<QU!177?"?PU9>,/B#H^CZBKM9W;2))Y;;6'[MB"#
MZ@@'\*Z3XK? '6_AS)+>6ZMJVA9)%Y"GS0CTE4=/]X<?3I7HT\OQ%7#/%TXW
M@G9VZ:)_=KN>=4S##4<5'!U)6G)75^NK6_?38\MHHHKSCT0HHHH **** "BB
MB@ HHHH **** "BBB@ HHKLO /PE\2_$:=1I5BRVF[:]]<?) G_ OXC[*"?:
MMJ-"KB)JG1BY2?1&%:O2P\'4K248KJSCT1I75$4L[' 51DDU]*_ _P#9M99+
M?7O%]MC&)+;2I!^(:4?^R?GZ5Z1\+/@#H7PW6.\E U;6P,_;9DPL1_Z9KSM^
MO)]QG%>HU^I9+PNJ#6(QVLND>B]>_IMZGY1GG%CQ">'P&D>LMF_3MZ[^@G3@
M<"EHHK]%/S4**** "BBB@ HHHH **** "BBB@ KX2^/7@L>"?B5J5O$FRRO#
M]MMO0(Y.5'L&##Z 5]V9QR>!7P+\9/&G_">?$/5=3CD\RS5_L]ISD>2G"D>S
M'+?\"-? <8NE]4IJ7Q\VGI;7]/P/T3@I5OKE1Q^#EU];Z?/?\3BJ***_(3]D
M"BBE +$ #)/ Q0!] ?LC^"?[0\0W_B:>/,&GI]GMV(X,SCYB/HG'_;05]7UQ
M?P?\%CP'\/=*TMTV79C\^Z]?.?YF!^G"_117:5_0&28'ZA@:=)KWGJ_5_P"6
MWR/YVSW'?VACZE5/W5HO1?Y[_,****]T\ **** "BBB@ HHHH **** "BBB@
M""]O(-.LY[NZE6"V@1I)97.%10,DD^@ KX-^+WQ(G^)GC"XU EDT^',-E"W&
MR('@D?WFZGZX["O8_P!JKXJ;5'@S39?F.V749%/0<%(OY,?^ ^]?,M?D?%6;
M>WJ_4:3]V/Q>;[?+\_0_8N$<H^KTOK]9>]+X?)=_G^7J%%%%?GQ^C!116AH.
MAWGB;6;/2M/B,]Y=R"*-!ZGN?0 9)/8 FJC%SDHQ5VR92C"+E)V2/2OV=?A;
M_P )]XL%_?0[M$TQEDFW#Y9I.J1^X[GV&.XK[6KF_A_X)LOA]X4LM%LL,(5S
M+-C!FE/WG/U/Y  =JZ2OWO),L65X54W\;UEZ]OD?SYGN:RS7%NHO@CI%>7?U
M?^2Z!1117T!\X%%%% !1110 4444 %8/C;PA9>.O#%]HM^O[FY3"R ?-&XY5
MQ[@X/Z5O45G4IQJP=.:NGHS2G4G1FJD'9K5,_./Q1X;O?"/B"^T?48_+N[20
MQN.S=PP]0001[$5EU]<?M1?"W_A(M!'BC3X<ZEIJ8N54<RV_7/U0DGZ%O05\
MCU^ 9QELLKQ4J+^'>+[K_@;,_HC)LSAFN$C77Q+22[/_ ">Z"BBBO%/<"OI/
M]E7XJ>7(?!NIS?*Q:33G<]#U>+\>6'ON'<5\V5-97D^G7D%W:RM!<P.LL4J'
M#(P.00?4$5ZF6X^IEN)CB(=-UW75?UU/*S/+Z>9X66&J==GV?1_UT/TJHKA_
MA!\2(/B9X/M]0!5-0AQ#>PKQLE Y(']UNH^N.QKN*_H*A7IXFE&M2=XR5T?S
MIB*%3"U94:JM*+LPHHHK<YPHHHH **** "BBB@#Y+_:T\<_VKXFL_#5M)FVT
MQ/-N .AG<9 _X"F/^^R*\#KZMUK]DM->U:]U*\\67$EU=S-/*WV(<LQ)/\?3
MFJ?_  QK9_\ 0TS_ /@$O_Q=?CN8Y)F^/Q53$2I;O3WH[=.O8_:<MSW)\OPE
M/#1J_"M?=EOUZ=SY>HKZA_X8UL_^AIG_ / )?_BZ/^&-;/\ Z&F?_P  E_\
MBZ\[_5C-?^?7_DT?\ST_]:LH_P"?O_DLO\CY>KZI_93^&,^CV=QXLU& Q37D
M?DV*.,,(<Y:3'^T0,>P)Z$5T_@O]F'PCX5NH[N[$VNW2'*_;<>2I]?+ P?\
M@1(KU_IP.!7UV1<-5,'66*Q;5ULEKKW?Z?>?&Y_Q/3QE!X3!IV>[>FG9?K?T
ML+1117Z*?FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &/XN\-6WC#PSJ6BW?\ J+R%HBV,E#U5A[A@"/I7Y^^*O"^H>#=>
MN](U2 P7=NVUA_"P[,I[J1R#7Z-5R_CCX;>'_B)9I;ZW8K.T8(BN$.R:+/\
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MX'Z]CX1DO=C[S^7^;LCYKB+'_P!GY?.47[TO=7J_\E=GME%%%?O1_/@4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHK[H^ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?GK\3_^2E>+?^PO=_\ HYZY
MFNF^)_\ R4KQ;_V%[O\ ]'/7,U_->*_WBIZO\S^GL+_N]/\ PK\D%%%%<QU'
MH7[/W_)8O#7_ %VD_P#13U]W5\(_L_?\EB\-?]=I/_13U]W5^P<&_P"XU/\
M&_R1^,\;?[_3_P "_-A1117WI^>A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5\-_M)?\EJ\1?\ ;M_Z315]R5\-_M)?\EJ\1?\
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MBBOK#Y **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[QJ7(N "Q"C)  SV%<O_ ,/3?BO_ -"_X-_\ KO_ .2:^>?VBO\ DX+XG?\
M8SZI_P"E<M>?5]_3P.&<(MP6Q\E/%5U)I2/V,_8R_:@G_:4\$ZK/K%M96'B?
M2;D1W=MIZ.D+1."89%#LQ&=KJ06/*$\9 KZ'K\7?V-/C5_PI'XZ:-J5W.T6@
MZD?[,U09^40R$;9#_N.$?/7 8=Z_:*OE<RPJPU;W5[KV/=P5=UJ7O;H****\
MH] **** "H;JZAL;:6XN)4AMX4,DDDC!510,DD]@!4U?*W_!1+XU'X9_!*3P
M_87!AUOQ6S6$>PX9+4 &X;\598_^VI]*WHTG7J1IQZF56HJ4'-]#YR\8?\%2
M?'D/BK5X_#F@^&)- 2ZD2PDOK6Y:=X Q",Y6=1N(P2 HQG%9/_#TWXK_ /0O
M^#?_  "N_P#Y)KXXHK[M9?A4K<B/E7BZ][\Q^U7[(_QHUOX]_!VV\6>(+73[
M/49+R>W,6FQND6U& !P[N<\\\U[37RQ_P38_Y-AL?^PI=_\ H0KZGKX?%14*
M\XQ6B;/I\/)RI1E+>P4445RG0?GA\>O^"A_Q'^%OQB\5^$])T7PO<:=I-XUO
M!+>6ERTS* #EBMPH)Y[ 5P7_  ]-^*__ $+_ (-_\ KO_P"2:\:_;&_Y.<^(
MO_84;_T%:\=K[VC@<-*E%N"O9'RE3%5E.24NI]C_ /#TWXK_ /0O^#?_  "N
M_P#Y)H_X>F_%?_H7_!O_ (!7?_R37QQ16WU#"_\ /M&7UNO_ #L^Q_\ AZ;\
M5_\ H7_!O_@%=_\ R31_P]-^*_\ T+_@W_P"N_\ Y)KXXHH^H87_ )]H/K=?
M^=GV/_P]-^*__0O^#?\ P"N__DFC_AZ;\5_^A?\ !O\ X!7?_P DU\<44?4,
M+_S[0?6Z_P#.S['_ .'IOQ7_ .A?\&_^ 5W_ /)-?J!I-T]_I=G<R!1)-"DC
M!> "5!./SK^?BOZ O#O_ "+^E_\ 7K%_Z *^?S;#TJ"A[.-KW_0]?+ZU2JY<
M[OL:-%%%?.'LGYX?'K_@H?\ $?X6_&+Q7X3TG1?"]QIVDWC6\$MY:7+3,H .
M6*W"@GGL!7!?\/3?BO\ ]"_X-_\  *[_ /DFO&OVQO\ DYSXB_\ 84;_ -!6
MO':^]HX'#2I1;@KV1\I4Q593DE+J?8__  ]-^*__ $+_ (-_\ KO_P"2:/\
MAZ;\5_\ H7_!O_@%=_\ R37QQ16WU#"_\^T9?6Z_\[/L?_AZ;\5_^A?\&_\
M@%=__)-3V?\ P50^)L<V;OPSX3GC_NPV]U&?S,[?RKXQHH_L_"_\^T'UNO\
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MB5%,L3'WRC(/^NAKLS/#JM0<K:QU_P SGP-9TJJ71Z'ZVT445\&?5A7YZ_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?A;^T5_R<%\3O\ L9]4_P#2N6O/J]!_:*_Y."^)
MW_8SZI_Z5RUY]7Z;1_AQ]$?$5/CEZA0K%&#*2K Y!'45[S\1/@BMK^RK\*OB
MAID&%NC>Z7J^Q?XQ?7)@F/U4&,D_W8QWKP:G3J1JIN/1M?<*<'!I/R?WG[4_
MLA_&@?'+X':)K5S/Y^N6:_V=JN?O&XC !<_[ZE'^KD=J]JK\G?\ @G+\;/\
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MN<8RQ4$U=K.\._\ (OZ7_P!>L7_H K1K\Y>Y]DM@HHHI#/Q._;&_Y.<^(O\
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M_>:GJSZS"_P8>@4445Q'2?B=^V-_R<Y\1?\ L*-_Z"M>.U[%^V-_R<Y\1?\
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M97/B?(_?BQM%L;&WMD8LD,:QJS=2 ,<_E5BBBORT^Z"OSU_X*T_\TJ_[BO\
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M_!AZ+\CXJM_$EZL_6S_@FQ_R;#8_]A2[_P#0A7U/7RQ_P38_Y-AL?^PI=_\
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M*7D89X!VJ0,]R.O2OT>4HTH-O1(^,BG.5ENSSNBOTZ_X=4_#[_H;O$WYV_\
M\:H_X=4_#[_H;O$WYV__ ,:KRO[6PO=_<>A_9]?M^)^8M%?IU_PZI^'W_0W>
M)OSM_P#XU1_PZI^'W_0W>)OSM_\ XU1_:V%[O[@_L^OV_$_,6BOTZ_X=4_#[
M_H;O$WYV_P#\:KX]_;"_9M@_9K^(&G:5IM[=:GHFI6(NK:ZO OF;PQ62,[0
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MJ]!_:*_Y."^)W_8SZI_Z5RUY]7Z;1_AQ]$?$5/CEZG[&_P#!/_\ Y-&\!_\
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M,E9:16W^9]/A,*L/&[^)A1117E'>%?GK_P %:?\ FE7_ '%?_;.OT*K\]?\
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MOP-:I.LHRDVC[9HHHKXT^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6*W\[^]A[&G_ "K[CQO_ (8[^"W_ $3K1O\ OVW_ ,51_P ,=_!;_HG6C?\
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M?C-XLC\-^%=9N+[5I(7G6*2PFA&Q!ECN90.]>T5^2/\ P39_Y.>L?^P7=_\
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MUYHHHKQ3TPHHHH XWXT?\D=\=_\ 8!O_ /TG>OP>K]X?C1_R1WQW_P!@&_\
M_2=Z_!ZOK<D^"?JCY_-/BB?L;_P3_P#^31O ?_;_ /\ I?<U]#5\\_\ !/\
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MPG5]E9IGVS1117DGH!17Y'_&#]N[XHWWQ0\42>$_&5QIOAI;^6/3K>&W@91
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MW8[_ '>7]=3Y(_8Y_P"3G/AU_P!A1?\ T%J_;&OQ._8Y_P"3G/AU_P!A1?\
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MY;:?BSBI<F)Q#G5>G]61[5I_["OP.L=)-A_P@MO<(R@--<7=PTS>^_S,J?\
M=P*^-?VT/V%[7X-Z$_C?P-+<S^&(Y%2_TVY?S)+'<0JR*_5HRQ"D'YE)!R03
MM^T/^&XO@;_T4"S_ / 6Y_\ C5<O\4/VN/@5XY^&_BGP])XZL;@:IIEQ:",V
MMP,L\;*N#Y?!R00>Q&:\+#U<=2J*4E)KK=,]2M3PM2#2<4^FQ^:7[.OQFO\
MX$?%C1?%-I(_V2.00:E;J>+BT<CS4([G ##T95/:OW$M;J*]MX;B"19H)D$D
M<B'*LI&00?0BOY\J_;?]DOQ!)XG_ &:_AU?2N9)!I$5LS'.3Y.8<G/4_N^O>
MN[.J*M"JM]CFRRH[RI_,\8_X*<?$:[\)_!/3/#MC,T$GB/4/*N&4X+6T2[W3
MUY<Q9]@1T-?G!\&_AE>_&3XG>'O!NGS+;7&K7'E&X9=PAC52\DFW(SM16;&1
MG'45^B/_  5&\$76N?!_P_XBM86F30]3*W)7/[J&=-N\^WF)$OU<>]?G/\*O
MB-J7PC^(>A>+](6.2_TFX\Y(IL[)%(*NC8YPRLR\>M=>6?[D_9?%K]_3]#GQ
MW^\^_MI]Q^L'@O\ 8&^"WA'38;>;PM_PD%VJ[9+[5KF25Y#ZE PC'_ 5%5O%
MW_!/;X*>*+.2.W\.7'A^Z92%NM*OI59??9(SI_X[7%>%?^"H?PQU6SA_MO1]
M?T&](_>HL$=S"IQ_"ZN&8=N4'7I7>:-_P4"^!NL.D;>+Y-/D8#"WNFW*#)&2
M"PC*C'N<>F:\*4<QA+F?-?YGJJ6#DK+E/*/@O_P33TSP+\4+C6O%NKV_BKP]
M8NLNE6'DE#._7=<J<C"'&%!(<\G RI^X0 H  P*P/!OQ \-?$/33?^&=?T[7
M[0'#2Z?<I,$/HVTG:?8X-=!7#B*]:O*]9ZHZJ-*G2C:FM&%%%%<IN%%%% !1
M110 4444 ?SV5^KG_!,7_DV^Z_[#UU_Z+AK\HZ_5S_@F+_R;?=?]AZZ_]%PU
M]QG'^[?-'S&7?Q_D?6]%%%?#GTX4444 <[\1O^2>^)_^P7=?^BFK\#J_?'XC
M?\D]\3_]@NZ_]%-7X'5]9D?PU/E^IX&:?%#YG[7_ +'7_)L7PZ_[!:_^A-7L
ME>-_L=?\FQ?#K_L%K_Z$U>R5\WB/XT_5_F>S1_AQ]$?+'_!2?_DV&^_["EI_
MZ$:_*/P[_P C!IG_ %]1?^ABOU<_X*3_ /)L-]_V%+3_ -"-?E'X=_Y&#3/^
MOJ+_ -#%?6Y1_NK]7^A\_F'\=>B/Z Z_(+_@HM"\?[5/B%F0JLEI9,A(^\/L
MZ#(_$$?A7Z^U^8__  5.\"RZ7\4/#'BR.(BTU;339R2!>/.@<GD^I25,9_N'
MTKQ<HDHXFSZIGIYC%RH771GSA\$?V=_&'[05YJMKX1BLYIM,CCEN%N[D0_*Y
M8*5SUY4_I7K/_#MGXT_\^.C?^#)?\*H?\$__ (QV'PE^.T4.LW*VFC>(+8Z9
M+/(<)#*65H78]AN79GH/,R>!D?K[7IX_'8C"UN6*5GMH<&#PM&O3YI-W/R1_
MX=L_&G_GQT;_ ,&2_P"%'_#MGXT_\^.C?^#)?\*_6ZN3U+XJ>$='\=Z;X+O?
M$%E;>*=2B::UTMY/WLBKU]@3S@$@MAL [3CSUF^*ELE]QVO+Z"W;^\^:/V"_
MV8_&_P"SYJWC&X\7P64,>J06L=O]DNA,24:0MG X^^*^D?C1_P D=\=_]@&_
M_P#2=Z[*N-^-'_)'?'?_ & ;_P#])WKS)UI8BNJD]VT=L:4:-+DCLC\'J_;_
M /97_P"3;_AK_P!@&T_]%BOQ K]O_P!E?_DV_P"&O_8!M/\ T6*^ESO^%#U/
M%RS^)+T/5****^//HCX;_P""K-M(WPT\$W QY<>KR1GGG+0DC_T$U\._LPW4
M=G^T7\-9)6VI_P )!9)GW:95'ZD5^C7_  4I\(2^)?V;)=0AB\Q]"U2VU!RJ
MY81D/ WX9F4G_=SVK\H]&U:ZT'6+'4[*3R;RRGCN8)/[LB,&4_@0*^URS]Y@
MW!>:/F,=[F)YGY,_H(HKSSX'?&OP]\=O 6G^(]#O(7EDB7[;8K(#+93X^:)U
MZC!S@D?,,$<&NH\8>,M%^'_AR]U[Q%J4&DZ39H9)KJX;:H]AW9CT"C))P ":
M^-E3E&7(UJ?2J491YD]#\J/^"D4\<W[4&IJC;FBTVS1QZ'R]V/R8?G7:_P#!
M*G_DL7BW_L G_P!*(J^8_CK\3I/C)\7/%'C)HF@35+LO!"_WD@11'"K>XC1
M<=P:^G/^"5/_ "6+Q;_V 3_Z415]MB(.GE[@]U%?H?+T9*IC.9;-L_3VO*/V
MI/A;_P +A^!/BSPY%%YNH-:F[L /O?:8CYD8'IN*[#[.:]7HKXFG-TY*<=T?
M42BIQ<7LS^>^&:6SN(Y8G:&:)@Z.IPRL#D$>A!K]6?CG^TE%>_L)Q^,[6X5-
M4\5Z=%I2>6P&VZE!CNE7'0H$N,8_NCI7P=^V5\+?^%2_M#>*-,AB$.F7TO\
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M&T"-;A&UO0;>/2M2M=PWHT:[8Y"/1T56SC&=X_A-?0%<-7-,52J2IR2T\O\
M@G33P%"I!33>I^2/_#MGXT_\^.C?^#)?\*/^';/QI_Y\=&_\&2_X5^L6JZM9
M:%IEUJ.HW<-A86L;33W5Q($CB11DLS'@ #N:R/ /Q"\.?%#PW!K_ (6U:#6M
M(F9D6XM\C#*<,K*0&4CT8 \@]"*C^UL5;FLK>A7]GT+VN[^I=\)V-SI?A?1K
M.];=>6]E##.V[=EU0!N>_(/-<#^T]\+/^%R? SQ7X:BB$NH26IN;#C)^U1?O
M(@/3<5V$^CFO5**\6-24)J:W3N>G**E%P>Q_/?#-+9W$<L3M#-$P='4X96!R
M"/0@U^K7QT_:0CO/V$XO&=M.L>J>+-.BTJ/80N+F4&.Z5<=-H2XQC^Z.E?"/
M[:'PK_X5+^T-XGTZ"(0Z9J,G]K6"J,*(9R6*J.P602(/9*\[U/XF:SJOPST/
MP//+G1M(O[K4(%R<EYEC!4^RE'(]Y7]J^ZJT88U4JJV3O\NWY'RE.K+"NI3?
M70R/"/AF^\:>*=(T#38_-U#5+N*RMT]9)'"KGVR:_>/P3X3L? ?@_1/#FFKL
ML=)LXK*'@ E8T"[CCN<9/J2:_,7_ ()F_"T^,/C;=^*KF+?8>%K0RHQZ?:I@
MT<0Q[)YS>Q5:_5:O#SFMS5(TET_-GJY;2Y8.H^IC>,/%>G>!?"NK^(M6F\C3
M-+M9+RX<<D(BEB .Y., =R0*_%W]H/\ :4\6_M"^*;B^UF]FM]%20FPT2&0B
MWM4'W?EZ-)CJYY)/&!@#]./V^KBXMOV3?'36YVEELT=@Q!"->P!L<<Y!QCC@
MGZ5^.=FL+7<"W+,EN742,G4+GDCWQFNG)J,.259K6]C#,JLN94UMN>P_"?\
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MJ<.(_P!]^:_0_9^BBBOBCZ8_&_\ ;^_Y.Y\>?]N'_I!;5[M_P2=_Y&#XC_\
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M^\T_5?F<V)_@S]&?D%7]"=?SV5_0G7NYY_R[^?Z'EY7]OY?J%?C1^W)\*_\
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ML1/$=TO^#^AX$J[J48T>W](_2_\ X)?_  L/AOX6ZUXVNX=EUXBNO(MF8?\
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M:XN/ %K'(3G;:7MU;)_WS%*J_I7:_#O]GOX;_"BX%UX4\'Z9I-X 5%X(S+<
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M/4_$;G6+C<,$(X A7Z>4J-]7-?2=06=G#I]G!:VT206\"+%%%&,*B@8"@=@
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MO4KGQ#K=S=ZE>:A.YEU&Z+.9I %+#<>I 9.!T!7H,5[=^P#_ ,G<^ _^W_\
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M=P=_D>-_9M5.RDK'Y$7?PC\3Z=\+8?B#>Z=)9>&KG48],M)[@%&NI'CED+1
MCYD41$%NF2 ,X;"?!?\ Y+%X$_[#UC_Z4)7Z&_\ !4[4;6S^"'A/25VQS3>(
M(YX8U  \N*VG5L#T!E3\Z_/WX!Z?)JWQS^'EG'G=-XAT]<@9VC[0F3CV&3^%
M>CA\0\3AY59*VYQUJ*HUE33OL?NQ1117Y^?7!1110!QOQH_Y([X[_P"P#?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<91P]#ZMAW=[>B_S'AL/4K5?;5EYG6T445\D?0A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139694034246176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 21,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APYX MEDICAL CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5115 Ulmerton Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Clearwater<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-2323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2644611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">APYX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000719135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>apyx-20231121_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="apyx-20231121.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <startDate>2023-11-21</startDate>
            <endDate>2023-11-21</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000719135</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">APYX MEDICAL CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-31885</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">11-2644611</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">5115 Ulmerton Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Clearwater</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33760</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">727</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">384-2323</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class A common stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">APYX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  @AWQ7VZ!>[S,$  !K$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V8:W/J-A"&_XK&G>FT,X?8,M>DP QQ2,N<7%S(Z>EE^D'8 C2Q)5<6(?S[
MK@S8M#4+:3X$R]:^/-*N7EGT-TJ_YBO.#7E/$YD/G)4QV8WKYM&*IRR_4AF7
M\&2A=,H,-/72S3/-65P$I8GK>U['39F0SK!?W OUL*_6)A&2AYKDZS1E>GO+
M$[49.-0YW)B*Y<K8&^ZPG[$EGW'S)0LUM-Q2)18IE[E0DFB^&#@C>G/KMVQ
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  @AWQ7&445]3<!   G @  #P
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  @AWQ799!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ((=\5YE<G",0!@
MG"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  @AWQ7VZ!>[S,$  !K$   &               @($."   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ((=\5Y^@&_"Q @
MX@P   T              ( !=PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  @AWQ7EXJ[',     3 @  "P              @ %3#P  7W)E;',O+G)E
M;'-02P$"% ,4    "  @AWQ7&445]3<!   G @  #P              @ $\
M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ((=\5R0>FZ*M    ^ $
M !H              ( !H!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ ((=\5V60>9(9 0  SP,  !,              ( !A1(
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  SQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="apyx-20231121.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apyxmedical.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="apyx-20231121.htm">apyx-20231121.htm</File>
    <File>apyx-20231121.xsd</File>
    <File>apyx-20231121_lab.xml</File>
    <File>apyx-20231121_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>apyx-20231121_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "apyx-20231121.htm": {
   "nsprefix": "apyx",
   "nsuri": "http://www.apyxmedical.com/20231121",
   "dts": {
    "inline": {
     "local": [
      "apyx-20231121.htm"
     ]
    },
    "schema": {
     "local": [
      "apyx-20231121.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "apyx-20231121_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "apyx-20231121_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.apyxmedical.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "apyx-20231121.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "apyx-20231121.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.apyxmedical.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000719135-23-000066-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000719135-23-000066-xbrl.zip
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M$GZA<@BZDD1AD9S9;1M 6*W:?,V<5]-^__GZ@FP?S%)0JD.[CF7@P1K6Q^5
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M][<+/-W.,.=89SW_GD4S1]SW _9"W-TA<]4Q;N:6>\K:,U!4Q^4D,'ARJA!
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MN\[WF0]_->VZ6G;9^?"7V["KSL-.:=W]K%:I//G9KWK#/CHZ>I*S7]3[.A
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ME37W7&NN;WT? 3>!FP=N/%%14P$(" B O_ _ &[AQH$RU,D> #0T #X  ,@
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MRBT<2IPO0\I3*2,_#55/E+*!O.T^-K&N5CME'6HB&E[K6>>PQ+Y,3%]>$9C
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M0GI4.&R#;^& JW3X$8^$G7# *4;_(Q4CVEVO)69 <ZQDUXUS@3U&V[CU5?,
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M^W2_6#","4T>:@_MK-3;)">X7;WT&"O9F+TY>%2J=:&D.<Q6VW" :1,1FSI
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MG(K%P>"#%0S3-+>+AO%K[ O'YC37XP&&WW1)F@4))J%B$1 R# %.?!\02A.
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M.VT-;6?::T>H#C3X1M"V_+;]G\;O[5%[KV.(*L['.;V:J4A%U(\(B'VB&\^
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MRSOOO/P\C"(U!\KDQT@?O4W@'CLW?X#TK<)H&D1A"=1:%V4-U(SL8BE#H L
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MF(VKQES#L\N=7=_0M3O:IFOWYM7QR9!,=&.PK_\6=NB[(*BB9 Z"\C8OWH&
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M?VXN0J'F=26 Z<B!,1-K7*?-#<.H;S3M3@X<)W$-$P/R_QYK-_EY6Q9KOY=
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M+^+,@,.'P0Q31T0S^Z"WLR+C0K<PL6CMZFB9#IEHUUXK_TL?NK6@6DTN[L
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MM&G.>G*2HK*3.DS'FN>:NW#_ 0*ICU5(]B:Y*<E !7LYCTNL2Z,0F6.J C_
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M,3(Q+FAT;5!+ 0(4 Q0    ( ""'?%>!P^,Y< (  (8'   1
M  "  >46  !A<'EX+3(P,C,Q,3(Q+GAS9%!+ 0(4 Q0    ( ""'?%<2^#NX
M,3D  &]5   4              "  809  !A<'EX+3(P,C,Q,3(Q7V<Q+FIP
M9U!+ 0(4 Q0    ( ""'?%>D78L2:@H  $M>   5              "  >=2
M  !A<'EX+3(P,C,Q,3(Q7VQA8BYX;6Q02P$"% ,4    "  @AWQ778,XV[$&
M  #P,   %0              @ &$70  87!Y>"TR,#(S,3$R,5]P<F4N>&UL
M4$L! A0#%     @ ((=\5Z$KD>-=0   "WX! !X              ( !:&0
M &%P>7AE;7!L;WEM96YT7V%G<F5E;65N='=I+FAT;5!+ 0(4 Q0    ( ""'
M?%?_9 <;J@T  'HR   >              "  0&E  !C9F]A<'!O:6YT;65N
G='!R97-S<F5L96%S92YH=&U02P4&      < !P#> 0  Y[(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
